JP6774767B2 - Topical skin composition - Google Patents
Topical skin composition Download PDFInfo
- Publication number
- JP6774767B2 JP6774767B2 JP2016053087A JP2016053087A JP6774767B2 JP 6774767 B2 JP6774767 B2 JP 6774767B2 JP 2016053087 A JP2016053087 A JP 2016053087A JP 2016053087 A JP2016053087 A JP 2016053087A JP 6774767 B2 JP6774767 B2 JP 6774767B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- external preparation
- preparation composition
- skin
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 103
- 230000000699 topical effect Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims description 125
- -1 polyoxyethylene Polymers 0.000 claims description 83
- 150000005215 alkyl ethers Chemical class 0.000 claims description 76
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 72
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 41
- 239000004094 surface-active agent Substances 0.000 claims description 32
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 30
- 239000000194 fatty acid Substances 0.000 claims description 30
- 229930195729 fatty acid Natural products 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 26
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims description 23
- 238000001816 cooling Methods 0.000 claims description 19
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 15
- 239000000600 sorbitol Substances 0.000 claims description 15
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 claims description 14
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 13
- 206010016334 Feeling hot Diseases 0.000 claims description 13
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 claims description 11
- 229940041616 menthol Drugs 0.000 claims description 11
- 239000003381 stabilizer Substances 0.000 claims description 8
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 claims description 4
- 229940078465 vanillyl butyl ether Drugs 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 3
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 claims description 3
- POEDHWVTLBLWDA-UHFFFAOYSA-N 1-butylindole-2,3-dione Chemical compound C1=CC=C2N(CCCC)C(=O)C(=O)C2=C1 POEDHWVTLBLWDA-UHFFFAOYSA-N 0.000 claims description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 1
- 239000003921 oil Substances 0.000 description 31
- 235000019198 oils Nutrition 0.000 description 31
- 239000002253 acid Substances 0.000 description 16
- 239000004615 ingredient Substances 0.000 description 16
- 239000000284 extract Substances 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 13
- 238000011156 evaluation Methods 0.000 description 13
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 239000003814 drug Substances 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000001771 impaired effect Effects 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 238000010792 warming Methods 0.000 description 7
- 239000004166 Lanolin Substances 0.000 description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 229940039717 lanolin Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000002040 relaxant effect Effects 0.000 description 6
- 229910052710 silicon Inorganic materials 0.000 description 6
- 239000010703 silicon Substances 0.000 description 6
- 150000005846 sugar alcohols Polymers 0.000 description 6
- 239000001993 wax Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 101150028517 hlb gene Proteins 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 229960004063 propylene glycol Drugs 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 229920002907 Guar gum Polymers 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000035597 cooling sensation Effects 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 235000010417 guar gum Nutrition 0.000 description 4
- 239000000665 guar gum Substances 0.000 description 4
- 229960002154 guar gum Drugs 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000010775 animal oil Substances 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 239000010696 ester oil Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 235000019477 peppermint oil Nutrition 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 239000003352 sequestering agent Substances 0.000 description 3
- 230000021148 sequestering of metal ion Effects 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000009834 vaporization Methods 0.000 description 3
- 230000008016 vaporization Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 2
- OVBFMEVBMNZIBR-UHFFFAOYSA-N 2-methylvaleric acid Chemical compound CCCC(C)C(O)=O OVBFMEVBMNZIBR-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 206010016352 Feeling of relaxation Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 2
- 241000772415 Neovison vison Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 240000000513 Santalum album Species 0.000 description 2
- 235000008632 Santalum album Nutrition 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940023476 agar Drugs 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 235000017663 capsaicin Nutrition 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 229940014259 gelatin Drugs 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229930007503 menthone Natural products 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 229940105132 myristate Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-M nonanoate Chemical compound CCCCCCCCC([O-])=O FBUKVWPVBMHYJY-UHFFFAOYSA-M 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 229960002446 octanoic acid Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000008601 oleoresin Substances 0.000 description 2
- 125000006353 oxyethylene group Chemical group 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- FBZQBGYPONNWCG-UHFFFAOYSA-N (4,5-dihydroxy-2,3-dimethoxyphenyl)-phenylmethanone Chemical compound COC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1OC FBZQBGYPONNWCG-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- AFSHUZFNMVJNKX-LLWMBOQKSA-N 1,2-dioleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC\C=C/CCCCCCCC AFSHUZFNMVJNKX-LLWMBOQKSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical class CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- LTSWUFKUZPPYEG-UHFFFAOYSA-N 1-decoxydecane Chemical compound CCCCCCCCCCOCCCCCCCCCC LTSWUFKUZPPYEG-UHFFFAOYSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- CZZVVHBOSHSEGG-UHFFFAOYSA-N 1-hydroxyethane-1,2-disulfonic acid Chemical compound OS(=O)(=O)C(O)CS(O)(=O)=O CZZVVHBOSHSEGG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- AOPDRZXCEAKHHW-UHFFFAOYSA-N 1-pentoxypentane Chemical class CCCCCOCCCCC AOPDRZXCEAKHHW-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- WPIOBXGJZUSKGK-UHFFFAOYSA-N 16-methylheptadecyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C WPIOBXGJZUSKGK-UHFFFAOYSA-N 0.000 description 1
- VRBHTEGUHVNKEA-UHFFFAOYSA-N 16-methylheptadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C VRBHTEGUHVNKEA-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- GOHZKUSWWGUUNR-UHFFFAOYSA-N 2-(4,5-dihydroimidazol-1-yl)ethanol Chemical compound OCCN1CCN=C1 GOHZKUSWWGUUNR-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- CKJYXTAGGUZBTB-UHFFFAOYSA-N 2-hexyldecyl 7,7-dimethyloctanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCC(C)(C)C CKJYXTAGGUZBTB-UHFFFAOYSA-N 0.000 description 1
- AVGLYNCSDWUUMH-UHFFFAOYSA-N 2-hydroxy-2-methyloctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(C)(O)C(O)=O AVGLYNCSDWUUMH-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- LAGDURGUNCQADL-UHFFFAOYSA-N 2-methylpropanoic acid;hydrochloride Chemical compound Cl.CC(C)C(O)=O LAGDURGUNCQADL-UHFFFAOYSA-N 0.000 description 1
- HTNFLUQQANUSLR-UHFFFAOYSA-N 2-octanoyloxyethyl octanoate Chemical compound CCCCCCCC(=O)OCCOC(=O)CCCCCCC HTNFLUQQANUSLR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- QNJOVLAFLJQFBF-UHFFFAOYSA-N 2-octyldodecyl 16-methylheptadecanoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C QNJOVLAFLJQFBF-UHFFFAOYSA-N 0.000 description 1
- PTPDZZWUOHQSLG-UHFFFAOYSA-N 2-octyldodecyl 2,2-dimethylpropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)(C)C)CCCCCCCC PTPDZZWUOHQSLG-UHFFFAOYSA-N 0.000 description 1
- ZIIVEKCKOPDBLT-UHFFFAOYSA-N 2-octyldodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)O)CCCCCCCC ZIIVEKCKOPDBLT-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- DQYSALLXMHVJAV-UHFFFAOYSA-M 3-heptyl-2-[(3-heptyl-4-methyl-1,3-thiazol-3-ium-2-yl)methylidene]-4-methyl-1,3-thiazole;iodide Chemical compound [I-].CCCCCCCN1C(C)=CS\C1=C\C1=[N+](CCCCCCC)C(C)=CS1 DQYSALLXMHVJAV-UHFFFAOYSA-M 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- IMCSHHYECBJTOO-UHFFFAOYSA-N 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol;octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCC(O)=O.CC1=NC=C(CO)C(CO)=C1O IMCSHHYECBJTOO-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 244000136475 Aleurites moluccana Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 241001673904 Argania Species 0.000 description 1
- 235000017519 Artemisia princeps Nutrition 0.000 description 1
- 244000065027 Artemisia princeps Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- YYSJNOKXVWYVKQ-UHFFFAOYSA-N CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCC(C)(C)C Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCC(C)(C)C YYSJNOKXVWYVKQ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- 102100037644 Kelch-like protein 41 Human genes 0.000 description 1
- 108050003242 Kelch-like protein 41 Proteins 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241001529735 Melissa Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- LMXFTMYMHGYJEI-UHFFFAOYSA-N Menthoglycol Natural products CC1CCC(C(C)(C)O)C(O)C1 LMXFTMYMHGYJEI-UHFFFAOYSA-N 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 206010029174 Nerve compression Diseases 0.000 description 1
- IXHRTTFMVZUWBW-UHFFFAOYSA-N OC(CS(=O)(=O)O)S(=O)(=O)O.[Na].[Na].[Na].[Na] Chemical compound OC(CS(=O)(=O)O)S(=O)(=O)O.[Na].[Na].[Na].[Na] IXHRTTFMVZUWBW-UHFFFAOYSA-N 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 235000006297 Origanum majorana Nutrition 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 235000011751 Pogostemon cablin Nutrition 0.000 description 1
- 240000002505 Pogostemon cablin Species 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004146 Propane-1,2-diol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000007769 Vetiveria zizanioides Nutrition 0.000 description 1
- 244000284012 Vetiveria zizanioides Species 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- PRLUQOOFPFWUKQ-KKTNLPSRSA-N [(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] (z)-octadec-9-enoate Chemical compound C1C[C@@H]2[C@@]3(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C[C@@H]3CC[C@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@]21C PRLUQOOFPFWUKQ-KKTNLPSRSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- GLLSGHWYBGERSE-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 GLLSGHWYBGERSE-UHFFFAOYSA-N 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- PCUSEPQECKJFFS-UHFFFAOYSA-N [3-tetradecanoyloxy-2,2-bis(tetradecanoyloxymethyl)propyl] tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC PCUSEPQECKJFFS-UHFFFAOYSA-N 0.000 description 1
- VKTHZHSHTVVWPN-UHFFFAOYSA-N [Na].[Na].[Na].[Na].[Na].CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCNCCN Chemical compound [Na].[Na].[Na].[Na].[Na].CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCNCCN VKTHZHSHTVVWPN-UHFFFAOYSA-N 0.000 description 1
- ADANNTOYRVPQLJ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilyl]oxy-dimethylsilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C ADANNTOYRVPQLJ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- PKVYKIKWKPWIMO-UHFFFAOYSA-N bis(2-butyloctyl) decanedioate Chemical compound CCCCCCC(CCCC)COC(=O)CCCCCCCCC(=O)OCC(CCCC)CCCCCC PKVYKIKWKPWIMO-UHFFFAOYSA-N 0.000 description 1
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229940057971 butane Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- BOUIEBMBWBCUPB-UHFFFAOYSA-N decyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCC BOUIEBMBWBCUPB-UHFFFAOYSA-N 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- KWABLUYIOFEZOY-UHFFFAOYSA-N dioctyl butanedioate Chemical compound CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC KWABLUYIOFEZOY-UHFFFAOYSA-N 0.000 description 1
- MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 239000010776 emu oil Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- DMMXZLMYEUEJFT-UHFFFAOYSA-N ethyl 16-methylheptadecanoate Chemical compound CCOC(=O)CCCCCCCCCCCCCCC(C)C DMMXZLMYEUEJFT-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- FPMPNVIMFPEKRN-UHFFFAOYSA-N hexyl 16-methylheptadecanoate Chemical compound CCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C FPMPNVIMFPEKRN-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- UWNADWZGEHDQAB-UHFFFAOYSA-N i-Pr2C2H4i-Pr2 Natural products CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 239000001780 majorana hortensis moench (origanum majorana l.) Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- GUMSHIGGVOJLBP-SLRPQMTOSA-N methyl hesperidin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 GUMSHIGGVOJLBP-SLRPQMTOSA-N 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- VNLRTFSQCPNNIM-UHFFFAOYSA-N octadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC VNLRTFSQCPNNIM-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- NPKKRSHVJIQBKU-UHFFFAOYSA-N ornogenin Natural products CC(OC(=O)C=Cc1ccccc1)C2(O)CCC3(O)C4(O)CC=C5CC(O)CCC5(C)C4CC(OC(=O)C=Cc6ccccc6)C23C NPKKRSHVJIQBKU-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 235000020744 piper nigrum extract Nutrition 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229940010310 propylene glycol dioleate Drugs 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 150000003376 silicon Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229950002760 sodium gualenate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940008424 tetradecamethylhexasiloxane Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229940095068 tetradecene Drugs 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- XWNXEWLCHSLQOI-UHFFFAOYSA-K trisodium;triacetate Chemical compound [Na+].[Na+].[Na+].CC([O-])=O.CC([O-])=O.CC([O-])=O XWNXEWLCHSLQOI-UHFFFAOYSA-K 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000001432 zingiber officinale rosc. oleoresin Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、バニリルアルキルエーテルの安定性を維持し、良好な温感をもたらすことができる皮膚外用剤組成物、特に、水を多く含有する水系でも、バニリルアルキルエーテルの安定性を維持し、良好な温感をもたらすことができる皮膚外用剤組成物に関する。 The present invention maintains the stability of vanillyl alkyl ether and maintains the stability of vanillyl alkyl ether even in a skin external preparation composition capable of providing a good feeling of warmth, particularly in an aqueous system containing a large amount of water. , With respect to a skin external preparation composition capable of providing a good feeling of warmth.
従来、皮膚外用剤組成物には、皮膚への適用時に温感を付与する成分が含有されていることがあり、温感を付与する物質として、ニコチン酸ベンジル、トウガラシエキス、ノニル酸バニリルアミド等が知られている。しかし、これらは温感が強いものの、配合量を増やすと皮膚刺激を起こす等の欠点があった。一方、バニリルアルキルエーテルは、低刺激であり、良好な温感をもたらすことが知られている(特許文献1)。しかし、水系の外用剤を調製するにあたり、多価アルコール及びエタノールと水との配合比率や、多価アルコールの種類によっては、バニリルアルキルエーテルの経時的安定性を得ることができず、特に高温保存下においては、その安定性の低下が顕著となる。こうした中、例えば、特許文献2には、バニリルブチルエーテル、特定の多価アルコール、エタノール、及び水の配合比率を制御することによりバニリルブチルエーテルの安定性を保持している。
しかしながら、これらの比率で調製した製剤では、水を40%より多く配合することができず、水系の外用剤において使用感を満足できるものが得ることができないため、水を多く配合してもバニリルアルキルエーテルを安定に保持できる製剤が望まれていた。
Conventionally, the external preparation composition for skin may contain a component that gives a warm feeling when applied to the skin, and as a substance that gives a warm feeling, benzyl nicotinate, capsicum extract, vanillyl amide nonylate, and the like are used. Are known. However, although these have a strong feeling of warmth, they have drawbacks such as causing skin irritation when the blending amount is increased. On the other hand, vanillyl alkyl ether is known to be mild and provide a good feeling of warmth (Patent Document 1). However, when preparing an aqueous external preparation, the stability of vanillyl alkyl ether over time cannot be obtained depending on the mixing ratio of polyhydric alcohol and ethanol with water and the type of polyhydric alcohol, and the temperature is particularly high. Under storage, the decrease in stability becomes remarkable. Under these circumstances, for example, Patent Document 2 maintains the stability of vanillyl butyl ether by controlling the blending ratio of vanillyl butyl ether, a specific polyhydric alcohol, ethanol, and water.
However, in the preparations prepared in these ratios, more than 40% of water cannot be blended, and it is not possible to obtain a water-based external preparation that satisfies the feeling of use. Therefore, even if a large amount of water is blended, vanillyl A preparation capable of stably holding the lylalkyl ether has been desired.
本発明は、バニリルアルキルエーテルを安定に保存できる製剤を提供する。また、本発明は、身体に塗布すると身体に温感を提供することにより、使用者のリラックス効果を高め、ひいては肩や首などの身体の凝りを低減できる皮膚外用剤組成物を提供する。 The present invention provides a preparation capable of stably storing vanillyl alkyl ether. Further, the present invention provides a skin external preparation composition that can enhance the relaxing effect of the user by providing a warm feeling to the body when applied to the body, and thus can reduce the stiffness of the body such as shoulders and neck.
本発明者らは上記目的を達成するために鋭意研究を重ねた結果、温感付与成分としてのバニリルアルキルエーテルに、ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤を配合する事で、バニリルアルキルエーテルの安定性を維持し、さらにバニリルアルキルエーテルの温感付与効果を身体に提供し、もって優れたリラックス感並びに肩や首などの凝りの低減が得られることを見出した。具体的に本発明は、以下の態様に関するものであり得る。 As a result of intensive studies to achieve the above object, the present inventors have selected vanillyl alkyl ether as a warming component from polyoxyethylene polyoxypropylene alkyl ether and polyoxyethylene sorbit fatty acid ester. By blending one or more kinds of surfactants, the stability of vanillyl alkyl ether is maintained, and the warming effect of vanillyl alkyl ether is provided to the body, which gives an excellent feeling of relaxation and shoulders and neck. It was found that a reduction in stiffness can be obtained. Specifically, the present invention may relate to the following aspects.
〔1〕
(a)バニリルアルキルエーテル、及び
(b)ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤、
を含むことを特徴とする、皮膚外用剤組成物。
〔2〕前記(b)成分/前記(a)成分の質量比が、1/10〜100/1である、前記〔1〕に記載の皮膚外用剤組成物。
〔3〕前記皮膚外用剤組成物の質量に対して40質量%以上の水を更に含有する、前記〔1〕又は〔2〕に記載の皮膚外用剤組成物。
〔4〕前記(a)成分が、バニリルブチルエーテル、バニリルプロピルエーテル、及びバニリルペンチルエーテルから選択される、前記〔1〕〜〔3〕のいずれか1項に記載の皮膚外用剤組成物。
〔5〕(c)成分として、メントール、l−メンチルグリセリルエーテル、及びエタノールから選択される冷涼感付与成分を更に含有する、前記〔1〕〜〔4〕のいずれか1項に記載の皮膚外用剤組成物。
〔6〕(d)成分として、ストレス軽減成分としてのシス−3−ヘキセン−1−オールを更に含有する、前記〔1〕〜〔5〕のいずれか1項に記載の皮膚外用剤組成物。
〔7〕前記(b)成分のHLBが10.5以下である、前記〔1〕〜〔6〕のいずれか1項に記載の皮膚外用剤組成物。
〔8〕塗布剤又は貼付剤である、前記〔1〕〜〔7〕のいずれか1項に記載の皮膚外用剤組成物。
〔9〕前記〔1〕〜〔8〕のいずれか1項に記載の皮膚外用剤組成物を含有する、温感を付与することにより身体の凝りを低減するための外用剤。
〔10〕ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤を含有する、バニリルアルキルエーテルの安定化剤。
[1]
One or more surfactants selected from (a) vanillyl alkyl ethers and (b) polyoxyethylene polyoxypropylene alkyl ethers and polyoxyethylene sorbitol fatty acid esters.
An external preparation composition for skin, which comprises.
[2] The skin external preparation composition according to the above [1], wherein the mass ratio of the component (b) to the component (a) is 1/10 to 100/1.
[3] The skin external preparation composition according to the above [1] or [2], which further contains 40% by mass or more of water with respect to the mass of the skin external preparation composition.
[4] The skin external preparation composition according to any one of the above [1] to [3], wherein the component (a) is selected from vanillyl butyl ether, vanillyl propyl ether, and vanillyl pentyl ether. ..
[5] The external application for skin according to any one of [1] to [4] above, further containing a cooling sensation-imparting component selected from menthol, l-menthylglyceryl ether, and ethanol as the component (c). Agent composition.
[6] The skin external preparation composition according to any one of the above [1] to [5], further containing cis-3-hexene-1-ol as a stress-reducing component as the component (d).
[7] The skin external preparation composition according to any one of [1] to [6] above, wherein the HLB of the component (b) is 10.5 or less.
[8] The external preparation composition for skin according to any one of [1] to [7] above, which is a coating agent or a patch.
[9] An external preparation for reducing body stiffness by imparting a feeling of warmth, which contains the skin external preparation composition according to any one of the above [1] to [8].
[10] A stabilizer for vanillyl alkyl ether, which contains one or more surfactants selected from polyoxyethylene polyoxypropylene alkyl ether and polyoxyethylene sorbitol fatty acid ester.
本発明は、温感付与成分としてのバニリルアルキルエーテルの経時的安定性(貯蔵安定性)を、ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤の存在により実現するものである。このような特定の界面活性剤の存在により、バニリルアルキルエーテルを長期間保存しても、バニリルアルキルエーテルが有する温感付与効果を確実に実現することができる。
本発明の皮膚外用剤組成物にさらに冷感付与成分を加えると、身体、特に首及び/又は肩に本発明の皮膚外用剤組成物を適用した場合、該冷涼感付与成分による即効的かつ持続的な冷涼感が生じる。この冷涼感の後に温感付与成分としてバニリルアルキルエーテルによる温感が生じる。この一連の過程において、相乗的な身体の凝り低減効果のみならず、温感付与成分と冷感付与成分による相乗的なリラックス感が得られるのである。更に、特有の香りを有するストレス軽減成分を加えることにより、リラックス効果を高めることができる。
従って、本発明は、身体塗布後の冷感と続く温感と共に、特有の香りも有することにより、使用者のリラックス効果を高め、もって肩や首などの凝りを低減できる皮膚外用剤組成物を提供する。
In the present invention, one or more interfaces selected from polyoxyethylene polyoxypropylene alkyl ether and polyoxyethylene sorbitol fatty acid ester for the temporal stability (storage stability) of vanillyl alkyl ether as a warming component. This is achieved by the presence of an activator. Due to the presence of such a specific surfactant, even if the vanillyl alkyl ether is stored for a long period of time, the warming effect of the vanillyl alkyl ether can be surely realized.
When a cold sensation-imparting ingredient is further added to the skin external preparation composition of the present invention, when the skin external preparation composition of the present invention is applied to the body, particularly the neck and / or shoulders, the cooling sensation-imparting ingredient has an immediate effect and lasts. A feeling of coolness occurs. After this cool feeling, a warm feeling is generated by vanillyl alkyl ether as a warm feeling imparting component. In this series of processes, not only a synergistic effect of reducing stiffness of the body but also a synergistic feeling of relaxation due to the warming sensation-imparting component and the cooling sensation-imparting component can be obtained. Furthermore, the relaxing effect can be enhanced by adding a stress-reducing ingredient having a unique scent.
Therefore, the present invention provides a skin external preparation composition capable of enhancing the relaxing effect of the user and reducing stiffness of the shoulders and neck by having a unique scent as well as a feeling of coldness and a continuous warmth after application to the body. provide.
本発明は、(a)バニリルアルキルエーテル、及び(b)ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤、を含むことを特徴とする、皮膚外用剤組成物、並びに当該皮膚外用剤組成物を含有する身体の凝りを低減するための外用剤に関する。更に本発明は、ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤を含有する、バニリルアルキルエーテルの安定化剤に関する。以下、各成分について詳細に説明する。 The present invention is characterized by comprising (a) a vanillyl alkyl ether and (b) one or more surfactants selected from polyoxyethylene polyoxypropylene alkyl ethers and polyoxyethylene sorbitol fatty acid esters. The present invention relates to an external preparation for skin, and an external preparation for reducing stiffness of the body containing the external preparation for skin. Furthermore, the present invention relates to a stabilizer for vanillyl alkyl ethers, which contains one or more surfactants selected from polyoxyethylene polyoxypropylene alkyl ethers and polyoxyethylene sorbitol fatty acid esters. Hereinafter, each component will be described in detail.
(a)バニリルアルキルエーテル
(a)成分のバニリルアルキルエーテルは、本発明の皮膚外用剤組成物における有効成分であり、低刺激性で、かつ、良好な温感をもたらす温感付与成分として使用される。ここで、温感とは、例えば本発明の組成物を湿布剤として使用した場合、当該湿布剤を患部(皮膚上)に適用すると暖かみを感じるものを言う。温感を付与するメカニズムに限定されないが、例えば(a)成分の作用により、血行が促進されるため、暖かみを感じる場合がある。
(a)成分のバニリルアルキルエーテルは、以下の一般式(I)で表される。
上記バニリルアルキルエーテルのアルキル基(上記一般式中のR1)は、置換されていてもいなくてもよく、直鎖または分岐鎖であってもよく、飽和または不飽和であってもよい、例えば炭素数が1〜10、好ましくは2〜8、より好ましくは3〜6のアルキル基であり得る。置換基としては、例えば、ハロゲン、炭素数が1〜10、好ましくは2〜8、より好ましくは3〜6のアルキル基が挙げられる。より具体的には、上記バニリルアルキルエーテルの好ましい例は、バニリルブチルエーテル、バニリルプロピルエーテル、及びバニリルペンチルエーテルから選択され得る。
(A) Vanillyl alkyl ether (a) The component vanillyl alkyl ether is an active ingredient in the external preparation composition for skin of the present invention, and is a hypoallergenic and warming component that provides a good warmth. used. Here, the term “warm feeling” refers to a feeling of warmth when the composition of the present invention is used as a poultice and the poultice is applied to the affected area (on the skin). Although not limited to the mechanism for imparting a feeling of warmth, for example, the action of the component (a) promotes blood circulation, so that a person may feel warmth.
The vanillyl alkyl ether of the component (a) is represented by the following general formula (I).
The alkyl group of the vanillyl alkyl ether (R 1 in the general formula above) may be substituted, linear or branched, saturated or unsaturated. For example, it can be an alkyl group having 1 to 10, preferably 2 to 8, more preferably 3 to 6 carbon atoms. Examples of the substituent include halogens and alkyl groups having 1 to 10, preferably 2 to 8 carbon atoms, and more preferably 3 to 6 carbon atoms. More specifically, preferred examples of the vanillyl alkyl ethers can be selected from vanillyl butyl ethers, vanillyl propyl ethers, and vanillyl pentyl ethers.
本発明の皮膚外用剤組成物における(a)成分の各1種の含有量は、皮膚外用剤組成物の全質量に対して0.001〜5質量%が適当であり、好ましくは0.05〜3質量%、より好ましくは0.01〜1質量%であり、特に好ましくは0.05〜0.5質量%である。この温感付与成分の各1種の含有量が0.001質量%以上であれば充分な温感が得られ、5質量%以下であれば、使用性を損なうこともないので好ましい。 The content of each one of the component (a) in the external preparation composition for skin of the present invention is appropriately 0.001 to 5% by mass, preferably 0.05, based on the total mass of the external preparation composition for skin. It is ~ 3% by mass, more preferably 0.01 to 1% by mass, and particularly preferably 0.05 to 0.5% by mass. When the content of each one of the warmth-imparting components is 0.001% by mass or more, a sufficient warmth is obtained, and when it is 5% by mass or less, usability is not impaired, which is preferable.
また、本発明の皮膚外用剤組成物における(a)成分の合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜20質量%が適当であり、好ましくは0.005〜15質量%、より好ましくは0.01〜10質量%、特に好ましくは0.05〜1質量%である。 The total content of the component (a) in the external preparation composition for skin of the present invention is, for example, 0.001 to 20% by mass, preferably 0, based on the total mass of the external preparation composition for skin. It is .005 to 15% by mass, more preferably 0.01 to 10% by mass, and particularly preferably 0.05 to 1% by mass.
(b)界面活性剤
本発明の皮膚外用剤組成物には、ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤を含有させることができる。
ポリオキシエチレンポリオキシプロピレンアルキルエーテルは、以下の一般式(II)のような構造を有する。
R2O[CH2CH3CHO]m[CH2CH2O]nH (II)
式(II)中、R2は、置換されていてもいなくてもよく、直鎖または分岐鎖であってもよく、飽和または不飽和であってもよい、例えば炭素数が1〜30、好ましくは3〜25、より好ましくは5〜20、さらに好ましくは8〜18のアルキル基であり得る。置換基としては、例えば、ハロゲン、炭素数が1〜20、好ましくは3〜15、より好ましくは6〜12のアルキル基が挙げられる。mは、例えば1〜50、好ましくは1〜35、より好ましくは3〜30であってもよい。nは、例えば1〜30、好ましくは2〜25、より好ましくは2〜20であってもよい。具体的なポリオキシエチレンポリオキシプロピレンアルキルエーテルとしては、例えば、ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル、ポリオキシエチレンポリオキシプロピレンセチルエーテル、ポリオキシエチレンポリオキシプロピレンデシルエーテル、等を挙げることができる。より具体的には、POE(n)POP(m)デシルテトラデシルエーテル、POE(n)POP(m)セチルエーテル、POE(n)POP(m)デシルエーテル、等を挙げることができる(ここでm及びnは上述の定義の通り)。
(B) Surfactant The external preparation composition for skin of the present invention may contain one or more surfactants selected from polyoxyethylene polyoxypropylene alkyl ether and polyoxyethylene sorbitol fatty acid ester.
The polyoxyethylene polyoxypropylene alkyl ether has a structure as shown in the following general formula (II).
R 2 O [CH 2 CH 3 CHO] m [CH 2 CH 2 O] n H (II)
In formula (II), R 2 may be substituted, linear or branched, saturated or unsaturated, eg, having 1-30 carbon atoms, preferably Can be 3-25, more preferably 5-20, even more preferably 8-18 alkyl groups. Examples of the substituent include a halogen and an alkyl group having 1 to 20, preferably 3 to 15, and more preferably 6 to 12 carbon atoms. m may be, for example, 1 to 50, preferably 1 to 35, and more preferably 3 to 30. n may be, for example, 1 to 30, preferably 2 to 25, and more preferably 2 to 20. Specific examples of the polyoxyethylene polyoxypropylene alkyl ether include polyoxyethylene polyoxypropylene decyltetradecyl ether, polyoxyethylene polyoxypropylene cetyl ether, polyoxyethylene polyoxypropylene decyl ether, and the like. it can. More specifically, POE (n) POP (m) decyltetradecyl ether, POE (n) POP (m) cetyl ether, POE (n) POP (m) decyl ether, and the like can be mentioned (here). m and n are as defined above).
ポリオキシエチレンソルビット脂肪酸エステルは、以下の一般式(III)のような構造を有する。
式(III)中、R3〜R5は、それぞれ独立に、置換されていてもいなくてもよく、直鎖または分岐鎖であってもよく、飽和または不飽和であってもよい、例えば炭素数が1〜30、好ましくは3〜25、より好ましくは5〜20、さらに好ましくは10〜18の脂肪酸エステル基、若しくは水素であり得る。s、t及びuは合計数で、例えば1〜100、好ましくは3〜80、より好ましくは5〜60であってもよい。各s、t及びuは同一であっても互いに±1〜10、もしくは±2〜5程度相違していてもよい。具体的なポリオキシエチレンソルビット脂肪酸エステルとしては、例えば、ポリオキシエチレンソルビットテトラオレイン酸エステル、ポリオキシエチレンソルビットテトラステアリン酸エステル、ポリオキシエチレンソルビットモノラウリン酸エステル、ポリオキシエチレンソルビットテトライソステアリン酸エステル等を挙げることができる。より具体的には、テトラオレイン酸POE(v)ソルビット、テトラステアリン酸POE(v)ソルビット、モノラウリン酸POE(v)ソルビット、テトライソステアリン酸POE(v)、等を挙げることができる(ここでvはs、t及びuの合計数を表す。)
The polyoxyethylene sorbitol fatty acid ester has a structure as shown in the following general formula (III).
In formula (III), R 3 to R 5 may be independently substituted, linear or branched, saturated or unsaturated, eg, carbon. The number can be 1-30, preferably 3-25, more preferably 5-20, still more preferably 10-18 fatty acid ester groups, or hydrogen. The total number of s, t and u may be, for example, 1 to 100, preferably 3 to 80, and more preferably 5 to 60. Each s, t and u may be the same or may differ from each other by about ± 1 to 10 or ± 2 to 5. Specific examples of the polyoxyethylene sorbit fatty acid ester include polyoxyethylene sorbit tetraoleic acid ester, polyoxyethylene sorbit tetrastearic acid ester, polyoxyethylene sorbit monolauric acid ester, and polyoxyethylene sorbit tetraisostearic acid ester. Can be mentioned. More specifically, POE (v) sorbitol tetraoleate, POE (v) sorbitol tetrastearate, POE (v) sorbitol monolaurate, POE tetraisostearate (v), and the like can be mentioned (here v). Represents the total number of s, t and u.)
前記(b)成分のHLB値は、例えば10.5以下、好ましくは9.7以下、より好ましくは8.7以下であることが適当であり、通常例えば0以上、好ましくは1以上、より好ましくは1以上であることが適当である。
HLB値は下記の計算式で算出される。
HLB = 20×((b)成分の親水部の分子量の総和/(b)成分の分子量)
The HLB value of the component (b) is preferably, for example, 10.5 or less, preferably 9.7 or less, more preferably 8.7 or less, and usually, for example, 0 or more, preferably 1 or more, more preferably. It is appropriate that is 1 or more.
The HLB value is calculated by the following formula.
HLB = 20 × (sum of molecular weight of hydrophilic part of component (b) / molecular weight of component (b))
(b)成分の界面活性剤は、(a)成分のバニリルアルキルエーテルの安定化剤として用いられる。また、(b)成分の界面活性剤は、可溶化剤や保湿成分としても用いられ得る。安定化剤として用いられる場合、(b)成分は、ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル、ポリオキシエチレンポリオキシプロピレンセチルエーテル、ポリオキシエチレンポリオキシプロピレンデシルエーテル、ポリオキシエチレンソルビットテトラオレイン酸エステル、ポリオキシエチレンソルビットテトラステアリン酸エステルであることが特に好ましい。
これら界面活性剤の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜20質量%が適当であり、好ましくは0.005〜10質量%、より好ましくは0.01〜6質量%、特に好ましくは0.05〜1質量%、殊更好ましくは0.08〜0.2質量%である。この量が0.001質量%以上であれば充分な保湿効果が得られ、20質量%以下であれば使用性を損なうこともないので好ましい。
また、前記(b)成分/前記(a)成分の質量比は、例えば1/10〜100/1であり、好ましくは1/1〜70/1であり、より好ましくは10/1〜50/1であり、特に好ましくは15/1〜40/1であり、殊更好ましくは25/10〜35/1である。
The surfactant of the component (b) is used as a stabilizer of the vanillyl alkyl ether of the component (a). In addition, the surfactant of the component (b) can also be used as a solubilizing agent or a moisturizing component. When used as a stabilizer, the component (b) is polyoxyethylene polyoxypropylene decyltetradecyl ether, polyoxyethylene polyoxypropylene cetyl ether, polyoxyethylene polyoxypropylene decyl ether, polyoxyethylene sorbit tetraoleic acid. Particularly preferably, the ester is a polyoxyethylene sorbit tetrastearic acid ester.
The content of these surfactants is preferably, for example, 0.001 to 20% by mass, preferably 0.005 to 10% by mass, and more preferably 0.01, based on the total mass of the external preparation composition for skin. It is ~ 6% by mass, particularly preferably 0.05 to 1% by mass, and particularly preferably 0.08 to 0.2% by mass. If this amount is 0.001% by mass or more, a sufficient moisturizing effect can be obtained, and if it is 20% by mass or less, usability is not impaired, which is preferable.
The mass ratio of the component (b) to the component (a) is, for example, 1/10 to 100/1, preferably 1/1 to 70/1, and more preferably 10/1 to 50 /. It is 1, particularly preferably 15/1 to 40/1, and particularly preferably 25/10 to 35/1.
(c)冷涼感付与成分
本発明の任意成分である冷涼感付与成分は、メントール、l−メンチルグリセリルエーテル及びエタノールから選択され得る。
これらメントール、l−メンチルグリセリルエーテル及びエタノールは皮膚に適用すると冷涼感が得られる。理論に拘束されないが、当該冷涼感は、皮膚から気化熱を奪う場合、皮膚の冷感点を刺激する場合等により冷たさを感じる場合がある。中でも、エタノールは、気化熱を奪う特性が他の冷涼感付与成分よりも高いので好ましい。特に、(c)成分を本発明の皮膚外用剤組成物に含めることにより、当該組成物を身体塗布した直後に冷涼感を、その後に温感を提供することができる。加えて特有の香りも有し、使用者のリラックス効果を高め、かつ肩や首などの凝りを低減できる外用剤を提供することができる。
(C) Cooling sensation-imparting component The cooling sensation-imparting component, which is an optional component of the present invention, can be selected from menthol, l-menthylglyceryl ether and ethanol.
When these menthol, l-menthylglyceryl ether and ethanol are applied to the skin, a cool feeling is obtained. Although not bound by theory, the cool sensation may be felt cold when the heat of vaporization is taken from the skin or when the cold sensation point of the skin is stimulated. Of these, ethanol is preferable because it has a higher property of removing heat of vaporization than other components that impart a feeling of cooling. In particular, by including the component (c) in the external preparation composition for skin of the present invention, it is possible to provide a cool feeling immediately after the composition is applied to the body and then a warm feeling. In addition, it can provide an external preparation that has a peculiar scent, enhances the relaxing effect of the user, and can reduce stiffness of the shoulders and neck.
理論に左右されないが、冷涼感付与成分として利用できるメントール及びl−メンチルグリセリルエーテルは、冷感を感じる神経に作用することで、冷涼感が得られる。メントール及びl−メンチルグリセリルエーテルのそれぞれの含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜5質量%が適当であり、好ましくは0.01〜3質量%、特に好ましくは0.1〜1質量%である。メントール及びl−メンチルグリセリルエーテルの含有量が0.001質量%以上であれば充分な冷涼感が得られ、5質量%以下であれば使用性を損なうこともないので好ましい。 Although not influenced by theory, menthol and l-menthylglyceryl ether, which can be used as cooling sensation-imparting components, act on nerves that feel cooling sensation to obtain a cooling sensation. The respective contents of menthol and l-menthylglyceryl ether are preferably, for example, 0.001 to 5% by mass, preferably 0.01 to 3% by mass, particularly, based on the total mass of the external preparation composition for skin. It is preferably 0.1 to 1% by mass. When the content of menthol and l-menthylglyceryl ether is 0.001% by mass or more, a sufficient cooling sensation can be obtained, and when it is 5% by mass or less, usability is not impaired, which is preferable.
本発明で使用できるエタノールは、医薬品や化粧品をはじめ、お酒等の食品、除菌剤等の雑貨品、石油化学工業、塗料工業など広く一般的に使用されるエタノールを使用することができる。市販されているエタノールには幾つかの純度のもの、例えば、純度77容量%、純度95容量%、純度99容量%等があるが、どの純度のエタノールも使用することができる。また、エタノール中にブルシン等の変成成分を配合し、飲用で使用できないように加工した種類も市販されているが、これも使用することができる。
本発明の皮膚外用剤組成物におけるエタノールの含有量は、エタノールの純度が95容量%であると仮定した場合(以下、エタノールの場合は同様)、皮膚外用剤組成物の全質量に対して、例えば3〜30質量%が適当であり、好ましくは5〜20質量%、特に好ましくは7〜15質量%である。エタノールの含有量が3質量%以上であれば充分な冷涼感が得られ、また30質量%以下であれば使用性を損なうこともないので好ましい。
As the ethanol that can be used in the present invention, ethanol that is widely and generally used in pharmaceuticals, cosmetics, foods such as alcohol, miscellaneous goods such as disinfectants, petrochemical industry, and paint industry can be used. Commercially available ethanol has several purity, for example, purity 77% by volume, purity 95% by volume, purity 99% by volume, etc., but any purity ethanol can be used. In addition, a type in which a metamorphic component such as brucine is mixed with ethanol and processed so that it cannot be used for drinking is commercially available, but this can also be used.
The content of ethanol in the external preparation composition for skin of the present invention is based on the total mass of the external preparation composition for skin, assuming that the purity of ethanol is 95% by mass (hereinafter, the same applies to ethanol). For example, 3 to 30% by mass is suitable, preferably 5 to 20% by mass, and particularly preferably 7 to 15% by mass. If the content of ethanol is 3% by mass or more, a sufficient cooling sensation can be obtained, and if it is 30% by mass or less, usability is not impaired, which is preferable.
本発明の皮膚外用剤組成物に含まれる冷涼感付与成分の合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.01〜40質量%が適当であり、好ましくは0.1〜30質量%、より好ましくは0.5〜20質量%、特に好ましくは1〜15質量%である。前記(c)成分/前記(a)成分の質量比は、例えば1/10〜300/1であり、好ましくは1/1〜200/1であり、より好ましくは10/1〜150/1であり、特に好ましくは50/1〜130/1であり、殊更好ましくは80/1〜120/1である。
上述の冷涼感付与成分としてメントール及び/又はl−メンチルグリセリルエーテルとエタノールとを使用する場合、メントール及びl−メンチルグリセリルエーテルの合計質量に対する冷涼感付与成分のエタノールの質量の比は、例えば[メントール及びl−メンチルグリセリルエーテルの合計質量]:[エタノールの質量]=1:100〜1:1が適当であり、好ましくは、1:70〜1:2、より好ましくは、1:50〜1:5、特に好ましくは、1:30〜1:10である。
The total content of the cooling sensation-imparting component contained in the skin external preparation composition of the present invention is, for example, 0.01 to 40% by mass, preferably 0, based on the total mass of the skin external preparation composition. .1 to 30% by mass, more preferably 0.5 to 20% by mass, and particularly preferably 1 to 15% by mass. The mass ratio of the component (c) to the component (a) is, for example, 1/10 to 300/1, preferably 1/1 to 200/1, and more preferably 10/1 to 150/1. It is particularly preferably 50/1 to 130/1, and particularly preferably 80/1 to 120/1.
When menthol and / or l-mentyl glyceryl ether and ethanol are used as the above-mentioned cooling sensation-imparting component, the ratio of the mass of ethanol of the cooling sensation-imparting component to the total mass of menthol and l-mentyl glyceryl ether is, for example, [menthol. And the total mass of l-menthol glyceryl ether]: [mass of ethanol] = 1: 100 to 1: 1, preferably 1: 70 to 1: 2, more preferably 1: 50 to 1: 1. 5, particularly preferably 1:30 to 1:10.
冷涼感付与成分として、メントール、l−メンチルグリセリルエーテル及びエタノール以外の成分(その他の冷涼感付与成分)を、本発明の効果を損なわない範囲で配合することができる。その他の冷涼感付与成分としては、例えば、メントン、カンファー、プレゴール、イソプレゴール、シネオール、ハッカオイル、ペパーミントオイル、スペアーミントオイル、ユーカリプタスオイル、N−アルキル−p−メンタン−3−カルボキサミド、2−メチル−3−(l−メントキシ)プロパン−1,2−ジオール、p−メンタン−3,8−ジオール、2−(l−メントキシ)エタン−1−オール、3−(l−メントキシ)プロパン−1−オール、4−(l−メントキシ)ブタン−1−オール、3−ヒドロキシブタン酸メンチル、乳酸メンチル、メントングリセリンケタール、N−メチル−2,2−イソプロピルメチル−3−メチルブタンアミド、またはグリオキシル酸メンチルを挙げることができる。本発明の皮膚外用剤組成物に含まれるその他の冷涼感付与成分の合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜5質量%が適当であり、好ましくは0.01〜3質量%、特に好ましくは0.1〜1質量%である。 As the cooling sensation-imparting component, components other than menthol, l-menthylglyceryl ether and ethanol (other cooling sensation-imparting components) can be blended within a range that does not impair the effects of the present invention. Other cooling sensation-imparting ingredients include, for example, menthone, camphor, pregol, isopulegol, cineole, butane oil, peppermint oil, spare mint oil, eucalyptus oil, N-alkyl-p-menthan-3-carboxamide, 2-methyl-. 3- (l-Mentoxy) Propane-1,2-diol, p-menthane-3,8-diol, 2- (l-mentoxy) ethane-1-ol, 3- (l-mentoxy) propane-1-ol , 4- (L-mentoxy) butane-1-ol, menthyl 3-hydroxybutanoate, menthyl lactate, menthone lycerin ketal, N-methyl-2,2-isopropylmethyl-3-methylbutaneamide, or menthyl glycylate Can be mentioned. The total content of the other cooling sensation-imparting components contained in the skin external preparation composition of the present invention is preferably, for example, 0.001 to 5% by mass, based on the total mass of the skin external preparation composition. Is 0.01 to 3% by mass, particularly preferably 0.1 to 1% by mass.
上述した(a)、(b)及び(c)の各成分の合計の含有量は、皮膚外用剤組成物の全質量に対して1〜50質量%が適当であり、好ましくは2〜40質量%、より好ましくは3〜30質量%、特に好ましくは5〜25質量%である。 The total content of each of the above-mentioned components (a), (b) and (c) is preferably 1 to 50% by mass, preferably 2 to 40% by mass, based on the total mass of the external preparation composition for skin. %, More preferably 3 to 30% by mass, and particularly preferably 5 to 25% by mass.
[その他の成分]
本発明の皮膚外用剤組成物には、上記成分の他、目的および剤形に応じて通常用いられる基剤成分並びに薬効成分等を配合することができる。そのような基剤成分並びに薬効成分の例として、鉱物・合成油、動植物油、ロウ類、脂肪酸、アルコール、エステル油、シリコン油、界面活性剤、湿潤剤、高分子化合物、動植物抽出物、アミノ酸類、溶剤、ビタミン類、消炎剤、防腐剤、紫外線吸収剤、金属イオン封鎖剤、酸化防止剤、pH調整剤、色素・顔料、香料などが挙げられる。これらその他の成分は、本発明の効果を損なわない範囲で配合することができる。その他の成分の含有量は、成分の種類にもよるが、たとえば、皮膚外用剤組成物の全質量に対して99〜50質量%が適当であり、好ましくは98〜60質量%、より好ましくは97〜70質量%、特に好ましくは95〜75質量%である。以下にその他の成分の具体例を挙げる。
(a)’その他の温感付与成分
上記(a)成分以外のその他の温感付与成分として、バニリルアルキルエーテル以外の成分を、本発明の効果を損なわない範囲で配合することができる。その他の温感付与成分としては、例えば、ショウキョウチンキ、トウガラシチンキ、カプサイシン、ギンゲロール、4−(l−メントキシメチル)−2−(3'−メトキシ−4'−ヒドロキシフェニル)−1,3−ジオキソラン、トウガラシ油、トウガラシオレオレジン、ジンジャーオレオレジン、ノニル酸バニリルアミド、ジャンブーオレオレジン、サンショウエキス、サンショール−I、サンショール−II、サンショウアミド、黒胡椒エキス、カビシン、ピペリンまたはスピラントールを挙げることができる。本発明の皮膚外用剤組成物に含まれるその他の温感付与成分の合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜5質量%が適当であり、好ましくは0.01〜3質量%、特に好ましくは0.1〜1質量%である。
[Other ingredients]
In addition to the above ingredients, the external preparation composition for skin of the present invention may contain a base ingredient, a medicinal ingredient and the like that are usually used depending on the purpose and dosage form. Examples of such base components and medicinal components include mineral / synthetic oils, animal and vegetable oils, waxes, fatty acids, alcohols, ester oils, silicon oils, surfactants, wetting agents, polymer compounds, animal and plant extracts, amino acids. Types, solvents, vitamins, anti-inflammatory agents, preservatives, UV absorbers, metal ion sequestering agents, antioxidants, pH regulators, pigments / pigments, fragrances and the like. These other components can be blended as long as the effects of the present invention are not impaired. The content of other components depends on the type of component, but for example, 99 to 50% by mass is appropriate, preferably 98 to 60% by mass, and more preferably 98% by mass, based on the total mass of the external preparation composition for skin. It is 97 to 70% by mass, particularly preferably 95 to 75% by mass. Specific examples of other components are given below.
(A)'Other warmth-imparting components As other warmth-imparting components other than the above-mentioned component (a), components other than vanillyl alkyl ether can be blended within a range that does not impair the effects of the present invention. Other warming-imparting ingredients include, for example, pepper tincture, ginger tincture, capsaicin, gingerol, 4- (l-mentoxymethyl) -2- (3'-methoxy-4'-hydroxyphenyl) -1,3. -Dioxolan, peppermint oil, peppermint oleoresin, ginger oleoresin, nonylate vanillylamide, jumbu oleoresin, sansho extract, sunshoal-I, sunshoal-II, sanshoamide, black pepper extract, capsaicin, piperin or spirantol Can be mentioned. The total content of the other warming-imparting components contained in the external preparation composition for skin of the present invention is preferably, for example, 0.001 to 5% by mass, based on the total mass of the external preparation composition for skin. Is 0.01 to 3% by mass, particularly preferably 0.1 to 1% by mass.
(b)’その他の界面活性剤
その他の界面活性剤としては、例えば、ラウリル硫酸塩、アルキル硫酸塩、ポリオキシエチレンアルキル硫酸塩、テトラデセンスルホン酸塩、ポリオキシエチレンアルキルスルホコハク酸塩、ラウロイルサルコシン塩、アルキルメチル−β−アラニン塩、ポリオキシエチレンアルキルエーテルリン酸塩、脂肪酸石けん、N−アシルグルタミン酸塩、ラウリン酸ジエタノールアミド、ヤシ油脂肪酸ジエタノールアミド、アルキルジメチルアミンオキシド、アルキルメチルタウリン塩、アルキルアミノプロキオン酸塩、ポリオキシエチレンアルキルエーテルカルボン酸塩、アルキルリン酸塩、アルキルグルコシド、ポリエーテル変性シリコン、塩化アルキルトリメチルアンモニウム、臭化アルキルトリメチルアンモニウム、アミドアミン、塩化ジアルキルジメチルアンモニウムジメチル酢酸ベタイン、アルキルアミドプロピルベタイン、アルキルカルボキシメチルヒドロキシエチルイミダゾリニウムベタイン、レシチン(大豆又は卵黄由来)およびその誘導体、プロピレングリコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンポリオキシプロピレングリコール、ポリオキシエチレンアルキルエーテル、ポリオキシプロピレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレンアルキルノニルフェニルエーテル、ポリオキシエチレンアルキルエーテルリン酸・リン酸塩、ショ糖脂肪酸エステル等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
これらその他の界面活性剤は、可溶化剤としても用いられるが、保湿成分としても用いられることがある。保湿成分として用いる場合、植物油のEO付加物である非イオン界面活性剤が特に優れており、1種以上を用いることができる。非イオン界面活性剤の中では、例えばポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油及びポリオキシエチレンポリオキシプロピレングリコールが好ましく用いられる。
これら非イオン界面活性剤の含有量は、皮膚外用剤組成物の全質量に対して0.001〜20質量%が適当であり、好ましくは0.01〜10質量%、特に好ましくは0.1〜6質量%である。この量が0.001質量%以上であれば充分な保湿効果が得られ、20質量%以下であれば使用性を損なうこともないので好ましい。
(B)'Other surfactants Examples of other surfactants include lauryl sulfate, alkyl sulfate, polyoxyethylene alkyl sulfate, tetradecene sulfonate, polyoxyethylene alkyl sulfosuccinate, and lauroyl sarcosin. Salts, alkylmethyl-β-alanine salts, polyoxyethylene alkyl ether phosphates, fatty acid soaps, N-acylglutamates, laurate diethanolamides, palm oil fatty acid diethanolamides, alkyldimethylamine oxides, alkylmethyl taurine salts, alkyls Aminoprocionate, polyoxyethylene alkyl ether carboxylate, alkyl phosphate, alkyl glucoside, polyether-modified silicon, alkyltrimethylammonium chloride, alkyltrimethylammonium bromide, amidoamine, dialkyldimethylammonium chloride dimethylacetate betaine, alkylamide Propyl betaine, alkylcarboxymethyl hydroxyethyl imidazolinium betaine, lecithin (derived from soybean or egg yolk) and its derivatives, propylene glycol fatty acid ester, glycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbit fatty acid ester, polyoxyethylene Hardened castor oil, polyethylene glycol fatty acid ester, polyoxyethylene polyoxypropylene glycol, polyoxyethylene alkyl ether, polyoxypropylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene alkyl nonylphenyl ether, polyoxyethylene alkyl Examples thereof include ether phosphate / phosphate, sucrose fatty acid ester, and among these, one type or a combination of two or more types can be used.
These other surfactants are also used as solubilizers, but may also be used as moisturizing ingredients. When used as a moisturizing component, a nonionic surfactant which is an EO adduct of vegetable oil is particularly excellent, and one or more kinds can be used. Among the nonionic surfactants, for example, polyoxyethylene glycerin fatty acid ester, polyoxyethylene cured castor oil and polyoxyethylene polyoxypropylene glycol are preferably used.
The content of these nonionic surfactants is preferably 0.001 to 20% by mass, preferably 0.01 to 10% by mass, and particularly preferably 0.1, based on the total mass of the external preparation composition for skin. ~ 6% by mass. If this amount is 0.001% by mass or more, a sufficient moisturizing effect can be obtained, and if it is 20% by mass or less, usability is not impaired, which is preferable.
(d)ストレス軽減成分
本発明の皮膚外用剤組成物には、特有の香りを有するストレス軽減成分としてシス−3−ヘキセン−1−オールを含有させることができる。
シス−3−ヘキセン−1−オールは、青葉アルコールとも呼ばれ、特有の香りを有するストレス軽減成分である。シス−3−ヘキセン−1−オールを化粧料等の皮膚外用剤組成物に含有させると、当該組成物を皮膚に塗布した後にシス−3−ヘキセン−1−オールが緩やかに揮発し、同時に香気が得られる。この香気を嗅ぐことでストレスが軽減しリラックス効果が得られ、ひいては肩や首等の身体の凝りを低減することができる。シス−3−ヘキセン−1−オールの揮発量は、前述の冷涼感付与成分の気化作用により相乗的に向上するので、本発明では冷涼感付与成分とシス−3−ヘキセン−1−オールとの組み合わせが重要である。
本発明の皮膚外用剤組成物に添加され得るシス−3−ヘキセン−1−オールは、医薬品や化粧品をはじめ、食品、雑貨品、石油化学工業、塗料工業など広く一般的に使用されるものである。本発明においては市販品を用いることができる。
本発明の皮膚外用剤組成物における特有の香りを有するシス−3−ヘキセン−1−オールの含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜20質量%が適当であり、好ましくは0.005〜10質量%、より好ましくは0.01〜5質量%、殊更好ましくは0.01〜3質量%、特に好ましくは0.1〜1質量%である。この量が0.001質量%以上であれば充分なストレス軽減によるリラックス効果が得られ、20質量%以下であれば使用性を損なうこともないので好ましい。
ストレス軽減成分として、シス−3−ヘキセン−1−オール以外の成分(その他のストレス軽減成分)を、本発明の効果を損なわない範囲で配合することができる。その他のストレス軽減成分としては、例えば、ラベンダー、メリッサ、ベンゾイン、ベルガモット、ベチバー、フランキンセンス、プチグレン、パチュリー、ネロリ、ゼラニウム、スィートマジョラム、サンダルウッド(ビャクダン)、サイプレス、クラリセージ、カモミールローマン、イランイランを挙げることができる。本発明の皮膚外用剤組成物に含まれるその他のストレス軽減成分の合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜5質量%が適当であり、好ましくは0.01〜3質量%、特に好ましくは0.1〜1質量%である。
(e)多価アルコール
多価アルコールとしては、例えば、グリセリン、ジグリセリン、ソルビット液、ポリエチレングリコール、プロピレングリコール、ジプロピレングリコール及び1,3−ブチレングリコール等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。本発明の皮膚外用剤組成物に含まれる多価アルコールの合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.01〜20質量%が適当であり、好ましくは0.1〜15質量%、特に好ましくは1〜10質量%である。
(D) Stress-reducing component The external preparation composition for skin of the present invention may contain cis-3-hexene-1-ol as a stress-reducing component having a unique scent.
Sis-3-hexene-1-ol, also called green leaf alcohol, is a stress-reducing ingredient with a unique scent. When cis-3-hexene-1-ol is contained in an external preparation composition for skin such as cosmetics, cis-3-hexene-1-ol slowly volatilizes after the composition is applied to the skin, and at the same time, aroma. Is obtained. By smelling this fragrance, stress can be reduced and a relaxing effect can be obtained, which in turn can reduce stiffness of the body such as shoulders and neck. Since the volatilization amount of cis-3-hexene-1-ol is synergistically improved by the vaporization action of the above-mentioned cooling sensation-imparting component, in the present invention, the cooling sensation-imparting component and cis-3-hexene-1-ol are used. The combination is important.
The cis-3-hexen-1-ol that can be added to the external preparation composition for skin of the present invention is widely and generally used in pharmaceuticals, cosmetics, foods, miscellaneous goods, petrochemical industry, paint industry and the like. is there. Commercially available products can be used in the present invention.
The content of cis-3-hexen-1-ol having a unique scent in the external preparation composition for skin of the present invention is, for example, 0.001 to 20% by mass, based on the total mass of the external preparation composition for skin. It is preferably 0.005 to 10% by mass, more preferably 0.01 to 5% by mass, particularly preferably 0.01 to 3% by mass, and particularly preferably 0.1 to 1% by mass. If this amount is 0.001% by mass or more, a relaxing effect due to sufficient stress reduction can be obtained, and if it is 20% by mass or less, usability is not impaired, which is preferable.
As the stress-reducing component, components other than cis-3-hexene-1-ol (other stress-reducing components) can be blended within a range that does not impair the effects of the present invention. Other stress-relieving ingredients include, for example, lavender, melissa, benzoin, bergamot, vetiver, frankincense, petitgrain, patchouli, neroli, geranium, sweet marjoram, sandalwood (sandalwood), cypress, clary sage, chamomile roman, and Iran Iran. be able to. The total content of the other stress-relieving ingredients contained in the external preparation composition for skin of the present invention is, for example, 0.001 to 5% by mass, preferably 0.001 to 5% by mass, based on the total mass of the external preparation composition for skin. It is 0.01 to 3% by mass, particularly preferably 0.1 to 1% by mass.
(E) Polyhydric alcohol Examples of the polyhydric alcohol include glycerin, diglycerin, sorbit solution, polyethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol and the like, and one of them or Two or more types can be used in combination. The total content of the polyvalent alcohol contained in the external preparation composition for skin of the present invention is, for example, 0.01 to 20% by mass, preferably 0.01 to 20% by mass, based on the total mass of the external preparation composition for skin. It is 1 to 15% by mass, particularly preferably 1 to 10% by mass.
(f)シリコン油
シリコン油としては、例えば、メチルポリシロキサン、ジメチルポリシロキサン、メチルフェニルポリシロキサン、シリコン樹脂、メチルハイドロジェンポリシロキサン、メチルシクロポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、環状シリコン樹脂、オクタメチルトリシロキサン、テトラデカメチルヘキサシロキサン、高重合メチルポリシロキサン、トリメチルシロキシケイ酸、ポリ(オキシエチレン・オキシプロピレン)メチルポリシロキサン共重合体、ポリ(オキシエチレン・オキシプロピレン)・ブチレン・メチルポリシロキサン共重合体、ポリオキシエチレン・メチルポリシロキ酸共重合体、ポリオキシプロピレン・メチルポリシロキサン共重合体、ジメチルポリシロキサン・メチルセチルオキシシロキサン共重合体、ジメチルシロキサン・メチルステアロキシシロキサン共重合体等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(F) Silicon oil Examples of silicon oil include methylpolysiloxane, dimethylpolysiloxane, methylphenylpolysiloxane, silicon resin, methylhydrogenpolysiloxane, methylcyclopolysiloxane, octamethylcyclotetrasiloxane, and decamethylcyclopentasiloxane. , Dodecamethylcyclohexasiloxane, cyclic silicon resin, octamethyltrisiloxane, tetradecamethylhexasiloxane, highly polymerized methylpolysiloxane, trimethylsiloxysilicate, poly (oxyethylene / oxypropylene) methylpolysiloxane copolymer, poly ( Oxyethylene / oxypropylene) / butylene / methylpolysiloxane copolymer, polyoxyethylene / methylpolysiloxyic acid copolymer, polyoxypropylene / methylpolysiloxane copolymer, dimethylpolysiloxane / methylcetyloxysiloxane copolymer , Dimethylsiloxane / Methylstealoxysiloxane copolymer and the like, and one or a combination of two or more of these can be used.
(g)防腐剤
防腐剤としては、例えば、メチルパラベン、エチルパラベン、プロピルパラベン、ブチルパラベン、イソブチルパラベン、フェノキシエタノール、ビサボロール、ヒノキチオール、安息香酸、安息香酸ナトリウム、サリチル酸、サリチル酸ナトリウム、ソルビン酸、ソルビン酸カリウム、ウンデシレン酸、ピオニン、l−メントール、d−カンフル、イソプロピルメチルフェノール、塩化ベンゼトニウム、塩酸アルキルジアミノエチルグリシン等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。本発明の皮膚外用剤組成物に含まれる防腐剤の合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜10質量%が適当であり、好ましくは0.01〜5質量%、特に好ましくは0.1〜1質量%である。
(h)増粘剤
増粘剤としては、例えば、カラギーナン(ι、λ、κ)、アルギン酸、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル、カルシウム含有アルギン酸ナトリウム、アルギン酸カリウム、アルギン酸カルシウム、アルギン酸アンモニウム等のアルギン酸塩及びその誘導体、キサンタンガム、グァーガム、ゼラチン、寒天、カルボキシメチルセルロースナトリウム、ヒドロキシエチルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシビニルポリマー(カルボマー)、アクリル酸系コポリマー、ポリアクリルアミド、ヒアルロン酸、ヒアルロン酸ナトリウム及びポリアクリル酸ナトリウム等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。本発明の皮膚外用剤組成物に含まれる増粘剤の合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜10質量%が適当であり、好ましくは0.01〜5質量%、特に好ましくは0.1〜1質量%である。
(G) Preservatives Examples of preservatives include methylparaben, ethylparaben, propylparaben, butylparaben, isobutylparaben, phenoxyethanol, bisabolol, hinokithiol, benzoic acid, sodium benzoate, salicylic acid, sodium salicylate, sorbic acid, potassium sorbate. , Undecylenoic acid, pionin, l-menthol, d-camfur, isopropylmethylphenol, benzethonium chloride, alkyldiaminoethylglycine hydrochloride and the like, and one or a combination of two or more of these can be used. The total content of the preservatives contained in the external preparation composition for skin of the present invention is, for example, 0.001 to 10% by mass, preferably 0.01, based on the total mass of the external preparation composition for skin. ~ 5% by mass, particularly preferably 0.1 to 1% by mass.
(H) Thickener Examples of the thickener include alginates such as carrageenan (ι, λ, κ), alginic acid, sodium alginate, propylene glycol alginate, calcium-containing sodium alginate, potassium alginate, calcium alginate, and ammonium alginate. And its derivatives, xanthan gum, guar gum, gelatin, agar, sodium carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, carboxyvinyl polymer (carbomer), alginic acid-based copolymers, polyacrylamide, hyaluronic acid, sodium hyaluronate, sodium polyacrylate, etc. Of these, one type or a combination of two or more types can be used. The total content of the thickener contained in the skin external preparation composition of the present invention is, for example, 0.001 to 10% by mass, preferably 0.001 to 10% by mass, based on the total mass of the skin external preparation composition. It is 01 to 5% by mass, particularly preferably 0.1 to 1% by mass.
(i)pH調整剤
pH調整剤としては、例えば、クエン酸、グリコール酸、リンゴ酸、酒石酸、乳酸、コハク酸、リン酸およびその塩、並びに水酸化ナトリウム、水酸化カリウム、炭酸水素ナトリウム等が挙げられる。これらのpH調整剤のうち、1種または2種以上を組み合わせて用いることができる。本発明の皮膚外用剤組成物に含まれるpH調整剤の合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜5質量%が適当であり、好ましくは0.005〜1質量%、特に好ましくは0.01〜0.1質量%である。
(j)溶剤
溶剤としては、例えば、精製水或いは常水等の水、イソプロパノール、並びにベンジルアルコール等のエタノール以外のアルコールが挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。溶剤の量は、本発明の皮膚外用剤組成物の各成分を加えた後の残部でかまわない。溶剤が水である場合、水の量の下限値は、皮膚外用剤組成物の全質量に対して、例えば、40質量%以上、好ましくは50質量%以上、より好ましくは60質量%以上、さらに好ましくは70質量%以上、特に好ましくは80質量%以上であることが適当であり、水の上限値は、例えば95質量%以下、好ましくは90質量%以下、より好ましくは85質量%以下、さらに好ましくは80質量%以下であることが適当である。溶剤が水以外である場合も上記下限値及び上限値を適用することができる。
溶剤として精製水或いは常水等の水を使用する場合、水の含有量は、皮膚外用剤組成物の全質量に対して1〜95質量%が適当であり、好ましくは10〜90質量%であり、より好ましくは50〜88質量%である。皮膚外用剤組成物が液体や粘性のある液状である場合は、当該水の含有量は、例えば60〜90質量%が適当であり、より好ましくは、65〜88質量%である。
(I) Acid adjuster Examples of the pH adjuster include citric acid, glycolic acid, malic acid, tartaric acid, lactic acid, succinic acid, phosphoric acid and salts thereof, and sodium hydroxide, potassium hydroxide, sodium hydrogen carbonate and the like. Can be mentioned. Of these pH regulators, one or a combination of two or more can be used. The total content of the pH adjuster contained in the external preparation composition for skin of the present invention is preferably, for example, 0.001 to 5% by mass, preferably 0.% by mass, based on the total mass of the external preparation composition for skin. It is 005 to 1% by mass, particularly preferably 0.01 to 0.1% by mass.
(J) Solvent Examples of the solvent include water such as purified water or normal water, isopropanol, and alcohols other than ethanol such as benzyl alcohol, and one or a combination of two or more of these may be used. it can. The amount of the solvent may be the balance after adding each component of the external preparation composition for skin of the present invention. When the solvent is water, the lower limit of the amount of water is, for example, 40% by mass or more, preferably 50% by mass or more, more preferably 60% by mass or more, and further, based on the total mass of the external preparation composition for skin. It is preferable that it is 70% by mass or more, particularly preferably 80% by mass or more, and the upper limit of water is, for example, 95% by mass or less, preferably 90% by mass or less, more preferably 85% by mass or less, and further. It is preferably 80% by mass or less. The above lower limit value and upper limit value can be applied even when the solvent is other than water.
When purified water or water such as normal water is used as the solvent, the content of water is preferably 1 to 95% by mass, preferably 10 to 90% by mass, based on the total mass of the external preparation composition for skin. Yes, more preferably 50-88% by mass. When the external preparation composition for skin is a liquid or a viscous liquid, the content of the water is, for example, 60 to 90% by mass, more preferably 65 to 88% by mass.
(k)油類
油類として、上記シリコン油以外に、鉱物、合成油、動植物油、ロウ、エステル油等を使用することができる。
具体的に、鉱物・合成油としては、例えば、流動パラフィン、流動イソパラフィン、ワセリン、パラフィン、セレシン、マイクロスタリンワックス、α−オレフィンオリゴマー、ポリエチレン、ポリブテン、合成スクワラン等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
動植物油としては、例えば、スクワラン、オリブ油、ツバキ油、コムギ胚芽油、ホホバ油、アボガド油、カロット油、シア脂、液状シア脂、パーム油、パーム核油、硬化油、馬油、ラノリン類、卵黄油、チョウジ油、ローズヒップ油、ラベンダー油、ハッカ油、スペアミント油、ローズマリー油、マカデミアナッツ油、杏仁油、サフラワー油、ヒマワリ油、メドゥホーム油、アーモンド油、エゴマ油、ゴマ油、ボラージ油、カカオ脂、コメヌカ油、コメ胚芽油、ウイキョウ油、オレンジ油、カミツレ油、キューカンバー油、ククイナッツ油、大豆油、トウモロコシ油、ナタネ油、パーシック油、ヒマシ油、綿実油、落花生油、タートル油、ミンク油、アルガニアスピサ核油、クランベアビシニカ種子油、アルモンド油、パーシック油、桃仁油、グレープシード油、エミュー油、ミンク油、アサ種子油、アマニ油、サザンカ油、モクロウ、ヤシ油、月見草油、ピスタシオ種子油、マンゴーバター等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(K) Oils In addition to the above silicon oils, minerals, synthetic oils, animal and vegetable oils, waxes, ester oils and the like can be used as oils.
Specifically, examples of the mineral / synthetic oil include liquid paraffin, liquid isoparaffin, petrolatum, paraffin, ceresin, microstalin wax, α-olefin oligomer, polyethylene, polybutene, synthetic squalane, and the like. Species or a combination of two or more can be used.
Animal and vegetable oils include, for example, squalane, olive oil, camellia oil, wheat germ oil, jojoba oil, avocado oil, carrot oil, shea butter, liquid shea butter, palm oil, palm kernel oil, hardened oil, horse oil, lanolins. , Egg yolk oil, butterfly oil, rose hip oil, lavender oil, peppermint oil, sparemint oil, rosemary oil, macadamia nut oil, apricot oil, saflower oil, sunflower oil, medu home oil, almond oil, egoma oil, sesame oil, borage Oil, cacao butter, rice bran oil, rice germ oil, oyster oil, orange oil, chamomile oil, cucumber oil, kukui nut oil, soybean oil, corn oil, rapeseed oil, persic oil, castor oil, cottonseed oil, peanut oil, turtle oil, Mink oil, Argania spisa kernel oil, Cranbear bicinica seed oil, Almond oil, Persic oil, Peach seed oil, Grape seed oil, Emu oil, Mink oil, Asa seed oil, Amani oil, Southern ka oil, Mokurou, Palm oil, Evening primrose oil , Pistacio seed oil, mango butter and the like, and one or a combination of two or more of these can be used.
ロウ類としては、例えば、ホホバ油、ミツロウ、カルナウバロウ、コメヌカロウ、鯨ロウ、ラノリン、液状ラノリン、還元ラノリン、硬質ラノリン、キャンデリラロウ、モンタンロウ、セラック、オレンジラフィー油等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
エステル油としては、例えば、トリカプリル酸グリセリル、トリ2−エチルヘキサン酸グリセリル、イソノナン酸イソノニル、ジオクタン酸エチレングリコール、トリ(カプリル酸/カプリン酸)グリセリル、ミリスチン酸イソプロピル、ミリスチン酸ブチル、パルミチン酸イソプロピル、ステアリン酸エチル、ステアリン酸ブチル、オレイン酸エチル、リノール酸エチル、リノール酸イソプロピル、カプリル酸セチル、ミリスチン酸デシル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、ミリスチン酸セチル、パルミチン酸セチル、ステアリン酸ステアリル、オレイン酸オレイル、オレイン酸デシル、リシノール酸セチル、ラウリン酸イソステアリル、ミリスチン酸イソトリデシル、ミリスチン酸イソセチル、ミリスチン酸イソステアリル、ミリスチン酸2−オクチルドデシル、パルミチン酸エチルヘキシル、パルミチン酸イソセチル、ステアリン酸エチルヘキシル、ステアリン酸イソセチル、オレイン酸イソデシル、オレイン酸2−オクチルドデシル、リシノール酸2−オクチルドデシル、イソステアリン酸エチル、イソステアリン酸イソプロピル、オクタン酸セチル、オクタン酸セトステアリル、オクタン酸ステアリル、イソステアリン酸ヘキシル、ジオレイン酸エチレングリコール、ジカプリン酸プロピレングリコール、ジ(カプリル・カプリン酸)プロピレングリコール、ジオレイン酸プロピレングリコール、ジカプリン酸ネオペンチルグリコール、ジ2−エチルヘキサン酸ネオペンチルグリコール、トリウンデシル酸グリセリル、トリイソパルミチン酸グリセリル、トリイソステアリン酸グリセリル、トリ2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ2−エチルヘキサン酸ペンタエリスリトール、テトラミリスチン酸ペンタエリスリトール、テトライソステアリン酸ペンタエリスリトール、ネオペンタン酸2−オクチルドデシル、オクタン酸イソセチル、オクタン酸イソステアリル、イソペアルゴン酸エチルヘキシル、ネオデカン酸2−ヘキシルデシル、ネオデカン酸2−オクチルドデシル、イソパルミチン酸エチルヘキシル、イソステアリン酸イソセチル、イソステアリン酸イソステアリル、イソステアリン酸2−オクチルドデシル、乳酸ラウリル、乳酸ミリスチル、乳酸セチル、乳酸2−オクチルドデシル、クエン酸トリエチル、クエン酸アセチルトリエチル、クエン酸アセチルトリブチル、クエン酸トリ2−エチルヘキシル、クエン酸トリイソセチル、クエン酸トリ2−オクチルドデシル、リンゴ酸ジイソステアリル、ヒドロキシステアリン酸2−エチルヘキシル、コハク酸ジオクチル、アジピン酸ジイソプロピル、アジピン酸ジイソブチル、アジピン酸ジオクチル、セバシン酸ジエチル、セバシン酸ジイソプロピル、セバシン酸ジオクチル、セバシン酸ジブチルオクチル、ステアリン酸コレステリル、イソステアリン酸コレステリル、ヒドロキシステアリン酸コレステリル、オレイン酸コレステリル、オレイン酸ジヒドロコレステリル、イソステアリン酸フィトステリル、オレイン酸フィトステリル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、フタル酸ジエチル、フタル酸ジブチル、炭酸ジアルキル等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
Examples of waxes include jojoba oil, beeswax, carnauba wax, rice wax, whale wax, lanolin, liquid lanolin, reduced lanolin, hard lanolin, candelilla wax, montan wax, celac, orange raffy oil and the like. One type or a combination of two or more types can be used.
Examples of the ester oil include glyceryl tricaprylate, glyceryl tri2-ethylhexanoate, isononyl isononanoate, ethylene glycol dioctanoate, glyceryl tri (caprylic acid / caprylic acid), isopropyl myristate, butyl myristate, and isopropyl palmitate. Ethyl stearate, butyl stearate, ethyl oleate, ethyl linoleate, isopropyl linoleate, cetyl caprylate, decyl myristate, hexyl laurate, myristyl myristate, cetyl myristate, cetyl palmitate, stearyl stearate, oleic acid Oleyl, decyl oleate, cetyl ricinolate, isostearyl laurate, isotolideyl myristate, isosetyl myristate, isostearyl myristate, 2-octyldodecyl myristate, ethylhexyl palmitate, isosetyl palmitate, ethylhexyl stearate, isosetil stearate , Isodecyl oleate, 2-octyldodecyl oleate, 2-octyldodecyl ricinolate, ethyl isostearate, isopropyl isostearate, cetyl octanate, cetostearyl octanate, stearyl octanate, hexyl isostearate, ethylene glycol dioleate, dicaprylic acid Propylene glycol acid, propylene glycol di (caprylic capric acid), propylene glycol dioleate, neopentyl glycol dicaprate, neopentyl glycol di2-ethylhexanate, glyceryl triundecylate, glyceryl triisopalmitate, glyceryl triisostearate, Trimethylolpropane tri2-ethylhexanoate, trimethylrolpropane triisostearate, pentaerythritol tetra2-ethylhexanoate, pentaerythritol tetramyristate, pentaerythritol tetraisostearate, 2-octyldodecyl neopentanoate, isocetyl octane, octane Isostearyl acid, ethylhexyl isoperanoate, 2-hexyldecyl neodecanoate, 2-octyldodecyl neodecanoate, ethylhexyl isopalmitate, isosetyl isostearate, isostearyl isostearate, 2-octyldodecyl isostearate, lauryl lactate, myristyl lactate, lactic acid Cetyl, 2-octyldodecyl lactate, triethyl citrate, ace citrate Tiltriethyl, acetyltributyl citrate, tri2-ethylhexyl citrate, triisocetyl citrate, tri2-octyldodecyl citrate, diisostearyl malate, 2-ethylhexyl hydroxystearate, dioctyl succinate, diisopropyl adipate, adipate Diisobutyl, dioctyl adipate, diethyl sebacate, diisopropyl sebacate, dioctyl sebacate, dibutyl octyl sebacate, cholesteryl stearate, cholesteryl isostearate, cholesteryl hydroxystearate, cholesteryl oleate, dihydrocholesteryl oleate, phytosteryl oleate Examples thereof include phytosteryl acid acid, hexyldecyl dimethyloctanoate, cetyl lactic acid, diethyl phthalate, dibutyl phthalate, dialkyl carbonate and the like, and one or a combination of two or more of these can be used.
(l)アルコール
アルコールとしては、冷涼感付与成分として用いられるエタノール以外のアルコールを本発明の皮膚外用剤組成物に添加することができる。アルコールとしては、例えば、イソプロパノール、ブチルアルコール、ベンジルアルコール、ラウリルアルコール、ミリスチルアルコール、セタノール、セトステアリルアルコール、ステアリルアルコール、イソステアリルアルコール、オレイルアルコール、ヘキシルデカノール、ベヘニルアルコール、オクチルドデカノール、ラノリンアルコール、コレステロール、フィトステロール、2−ヘキシルデカノール、2−オクチルドデカノール、バチルアルコール等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(m)脂肪酸
脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸、ベヘニン酸、リノール酸、リノレン酸、ドコサヘキサエン酸、エイコサペンタエン酸、12−ヒドロキシステアリン酸、ウンデシレン酸、ラノリン脂肪酸等の天然脂肪酸、イソノナン酸、カプロン酸、2−エチルブタン酸、イソペンタン酸、2−メチルペンタン酸、イソペンタン酸等の合成脂肪酸等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(n)湿潤剤
湿潤剤としては、上記多価アルコールの他、例えば、酸化エチレン、エチレングリコールモノエチルエーテル、エチレングリコールモノブチルエーテル、ジエチレングリコールモノエチルエーテル、酸化プロピレン、ポリオキシアルキレンアルキルエーテル等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(L) Alcohol As the alcohol, an alcohol other than ethanol used as a cooling sensation-imparting component can be added to the skin external preparation composition of the present invention. Examples of alcohols include isopropanol, butyl alcohol, benzyl alcohol, lauryl alcohol, myristyl alcohol, setanol, cetostearyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, hexyldecanol, behenyl alcohol, octyldodecanol, lanolin alcohol, cholesterol and phytosterol. , 2-Hexyldecanol, 2-octyldodecanol, batyl alcohol and the like, and one or a combination of two or more of these can be used.
(M) Fatty Acids Examples of fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, behenic acid, linoleic acid, linolenic acid, docosahexaenoic acid, eicosapentaenoic acid, and 12-hydroxystearic acid. Natural fatty acids such as undosilenic acid and lanolin fatty acid, synthetic fatty acids such as isononanoic acid, caproic acid, 2-ethylbutanoic acid, isopentanoic acid, 2-methylpentanoic acid and isopentanoic acid can be mentioned, and one or two of these can be mentioned. The above can be used in combination.
(N) Wetting agent In addition to the above polyhydric alcohol, examples of the wetting agent include ethylene oxide, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, diethylene glycol monoethyl ether, propylene oxide, and polyoxyalkylene alkyl ether. , Of these, one type or a combination of two or more types can be used.
(o)高分子化合物
高分子化合物としては、例えば、アルギン酸ナトリウム、カラギーナン、寒天、ファーセレラン、グァーガム、クインスシード、コンニャクマンナン、タマリンドガム、タラガム、デキストリン、デンプン、ローカストビーンガム、アラビアガム、ガッティガム、カラヤガム、トラガカントガム、アラビノガラクタン、ペクチン、マルメロ、小麦タンパク質、大豆タンパク質、アルブミン、カゼイン、ゼラチン、キトサン、ヒアルロン酸、カードラン、キサンタンガム、ジェランガム、シクロデキストリン、デキストラン、プルラン、ヒアルロン酸、結晶セルロース、メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース、カチオン化セルロース、カチオン化グァーガム、ヒドロキシプロピル化グァーガム、カルボキシビニルポリマー、ポリアクリル酸アミド、ポリアクリル酸ナトリウム、ポリエチレンイミン、高重合ポリエチレングリコール、ポリビニルアルコール、ポリビニルピロリドン等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(p)動植物抽出物
動植物抽出物としては、例えば、プラセンタエキス、加水分解ケラチン、加水分解シルク、酵母エキス、アロエエキス、コンフリーエキス、シャクヤクエキス、シソエキス、セージエキス、センブリエキス、ハマメリス水、ヒキオコシエキス、ホップエキス、マロニエエキス、モモ葉エキス、ユキノシタエキス、メリッサエキス、ヨモギエキス、ローズマリーエキス、コメヌカ発酵エキス等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(O) Polymer compound Examples of the polymer compound include sodium alginate, carrageenan, agar, farcerelan, guar gum, quince seed, konjak mannan, tamarind gum, tara gum, dextrin, starch, locust bean gum, arabic gum, gatti gum, and karaya gum. , Tragacanth gum, arabinogalactan, pectin, malmero, wheat protein, soybean protein, albumin, casein, gelatin, chitosan, hyaluronic acid, carrageenan, xanthan gum, gellan gum, cyclodextrin, dextrin, purulan, hyaluronic acid, crystalline cellulose, methylcellulose, Ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, carboxymethyl cellulose, cationized cellulose, cationized guar gum, hydroxypropylated guar gum, carboxyvinyl polymer, polyacrylic acid amide, sodium polyacrylate, polyethylene imine, highly polymerized polyethylene glycol , Polyvinyl alcohol, polyvinyl pyrrolidone and the like, and one or a combination of two or more of these can be used.
(P) Animal and plant extracts Examples of animal and plant extracts include placenta extract, hydrolyzed keratin, hydrolyzed silk, yeast extract, aloe extract, comfrey extract, shakyaku extract, perilla extract, sage extract, sembly extract, hamamelis water, and hikiokoshi. Examples include extracts, hop extracts, marronnier extracts, peach leaf extracts, yukinoshita extracts, melissa extracts, yomogi extracts, rosemary extracts, fermented rice bran extracts, etc., and one or more of these can be used in combination. ..
(q)アミノ酸類
アミノ酸類としては、例えば、L−アラニン、L−アルギニン、L−アスパラギン酸、L−グルタミン、L−アスパラギン、L−システイン、L−セリン、L−チロシン、L−プロリン、ピロリドンカルボン酸塩、グリシン、バリン、ロイシン、イソロイシン、トレオニン、メチオニン、フェニルアラニン、トリプトファン、リシン、シスチン、ヒドロキシプロリン、ヒドロキシリジン、オルニチン、ヒスチジン、γ−アミノ酪酸、ε−アミノカプロン酸等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(r)ビタミン類
ビタミン類としては、例えば、レチノール、レチノイン酸、ビタミンA油、酢酸レチノール、パルミチン酸レチノール、β−カロチン、リコピン、アスタキサンチン、ルテイン、クリプトキサンチン、塩酸ピリドキシン、ジカプリル酸ピリドキシン、ビオチン、ニコチン酸、ニコチン酸アミド、ニコチン酸ベンジル、リボフラビン、葉酸、パントテン酸カルシウム、D−パントテニルアルコール、アスコルビン酸、パルミチン酸アスコルビル、リン酸L−アスコルビルマグネシウム、テトラ2−ヘキシルデカン酸アスコルビル、L−アスコルビン酸2−グルコシド、アスコルビン酸−2−リン酸パルミチン酸ナトリウム、アスコルビルエチル、エルゴカルシフェロール、dl−α−トコフェロール、dl−α−酢酸トコフェロール、天然ビタミンE、ユビキノン、カルニチン、α−リポ酸、ビタミンP(ヘスペリジン、メチルヘスペリジン、ルチン)等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(Q) Amino acids Examples of amino acids include L-alanine, L-arginine, L-aspartic acid, L-glutamine, L-aspartin, L-cysteine, L-serine, L-tyrosine, L-proline, and pyrrolidone. Examples thereof include carboxylate, glycine, valine, leucine, isoleucine, threonine, methionine, phenylalanine, tryptophan, lysine, cystine, hydroxyproline, hydroxylysine, ornithine, histidine, γ-aminobutyric acid, ε-aminocaproic acid, etc. Of these, one type or a combination of two or more types can be used.
(R) Vitamins Examples of vitamins include retinol, retinoic acid, vitamin A oil, retinol acetate, ascorbyl palmitate, β-carotene, lycopene, ascorbyl, lutein, cryptoxanthin, pyridoxin hydrochloride, pyridoxin dicaprylate, and biotin. Nicotinic acid, nicotinic acid amide, benzyl nicotinate, riboflavin, folic acid, calcium pantothenate, D-pantothenyl alcohol, ascorbic acid, ascorbyl palmitate, L-ascorbyl magnesium phosphate, ascorbyl tetra2-hexyldecanoate, L-ascorbic acid 2-glucoside, ascorbic acid-2-ascorbyl palmitate, ascorbyl ethyl, ergocalciferol, dl-α-tocopherol, dl-α-tocopherol acetate, natural vitamin E, ubiquinone, carnitine, α-lipoic acid, vitamin P (Hesperidin, methyl hesperidin, rutin) and the like can be mentioned, and one or a combination of two or more of these can be used.
(s)消炎剤
消炎剤としては、例えば、グリチルリチン酸、グリチルリチン酸ジカリウム、グリチルリチン酸モノアンモニウム、グリチルレチン酸、グリチルレチン酸ステアリル、グアイアズレン、グアイアズレンスルホン酸ナトリウム、アラントイン、ε−アミノカプロン酸等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(t)紫外線防止剤
紫外線防止剤としては、例えば、パラアミノ安息香酸、パラアミノ安息香酸エチル、パラアミノ安息香酸グリセリル、パラジメチルアミノ安息香酸2−エチルヘキシル、オキシベンゾン、ジヒドロキシベンゾフェノン、ジヒドロキシジメトキシベンゾフェノン、ジヒドロキシジメトキシベンゾフェノンスルホン酸ナトリウム、ヒドロキシメトキシベンゾフェノンスルホン酸ナトリウム、サリチル酸オクチル、4−tert−ブチル−4’−メトキシ−ジベンゾイルメタン、フェルラ酸、酸化チタン、微粒子酸化チタン、酸化亜鉛、微粒子酸化亜鉛等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(u)金属イオン封鎖剤
金属イオン封鎖剤としては、例えば、エデト酸、エデト酸塩、エチレンジアミンヒドロキシエチル三酢酸三ナトリウム、ジエチレントリアミン五酢酸、ジエチレントリアミン五酢酸五ナトリウム、エチレンジアミンテトラキス(2−ヒドロキシイソプロピル)ジオレイン酸塩、ヒドロキシエタンジスルホン酸、ヒドロキシエタンジスルホン酸四ナトリウム、フィチン酸等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(v)酸化防止剤
酸化防止剤としては、例えば、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、エリソルビン酸、没食子酸プロピル、d−δ−トコフェロール等が挙げられ、これらのうち、1種または2種以上を組み合わせて用いることができる。
(w)香料
香料としては、上記(d)のストレス軽減成分として加えられるシス−3−ヘキセン−1−オールのような香料以外の、動物系、植物系、鉱物系の天然香料および合成香料のいずれも使用可のであり、これらのうち、1種または2種以上を組み合わせて用いることができる。本発明の皮膚外用剤組成物に含まれる香料の合計の含有量は、皮膚外用剤組成物の全質量に対して、例えば0.001〜10質量%が適当であり、好ましくは0.01〜5質量%、特に好ましくは0.1〜1質量%である。
(S) Anti-inflammatory agent Examples of the anti-inflammatory agent include glycyrrhizinic acid, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, glycyrrhetinic acid, stearyl glycyrrhetinate, guaiazulene, sodium guaiazulene sulfonate, allantoin, ε-aminocaproic acid and the like. Of these, one type or a combination of two or more types can be used.
(T) UV inhibitor Examples of the UV inhibitor include para-aminobenzoic acid, ethyl para-aminobenzoate, glyceryl para-aminobenzoate, 2-ethylhexyl para-dimethylaminobenzoate, oxybenzone, dihydroxybenzophenone, dihydroxydimethoxybenzophenone, and dihydroxydimethoxybenzophenone sulfone. Examples thereof include sodium acid, sodium hydroxymethoxybenzophenone sulfonate, octyl salicylate, 4-tert-butyl-4'-methoxy-dibenzoylmethane, ferulic acid, titanium oxide, fine particle titanium oxide, zinc oxide, fine particle zinc oxide and the like. Of these, one type or a combination of two or more types can be used.
(U) Metal ion sequestering agent Examples of the metal ion sequestering agent include edetic acid, edetate, ethylenediaminehydroxyethyl triacetate trisodium, diethylenetriamine pentaacetic acid, diethylenetriamine pentaacetic acid pentasodium, and ethylenediaminetetrakis (2-hydroxyisopropyl) diolein. Examples thereof include acid salts, hydroxyethanedisulfonic acid, tetrasodium hydroxyethanedisulfonic acid, phytic acid and the like, and one or a combination of two or more of these can be used.
(V) Antioxidant Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, erythorbic acid, propyl gallate, d-δ-tocopherol, and the like, and one or more of these may be used. It can be used in combination.
(W) Fragrances As fragrances, natural fragrances of animal, plant, minerals and synthetic fragrances other than fragrances such as cis-3-hexene-1-ol added as the stress-reducing component of (d) above. Any of these can be used, and one or a combination of two or more of these can be used. The total content of the fragrance contained in the external preparation composition for skin of the present invention is, for example, 0.001 to 10% by mass, preferably 0.01 to 10% by mass, based on the total mass of the external preparation composition for skin. It is 5% by mass, particularly preferably 0.1 to 1% by mass.
[皮膚外用剤組成物の形態]
本発明は、皮膚外用剤組成物に関する。ここで「外用剤」とは、内服薬及び注射薬を除いた、身体へ直接適用する薬剤を意味し、特に皮膚(外皮)に適用する薬剤を意味する。外用剤としては、例えば、軟膏、クリーム、ジェル、ローション、乳液、ヘアトニックのような塗布剤;並びに、パップ剤、プラスター剤、テープ剤、パッチ剤のような貼付剤を挙げることができる。外用剤は、医薬品、医薬部外品、化粧品であり得る。皮膚外用剤組成物は、当該外用剤に用いられる組成物を意味する。
本発明の皮膚外用剤組成物の使用量は、外用剤の種類にもよるが、通常の外用剤で用いられる量であってよい。当該皮膚外用剤組成物の使用量は、例えば、身体の皮膚表面100cm2当たり、0.01〜10g、好ましくは、0.05〜5g、より好ましくは、0.1〜1gであることが適当である。
[Form of external preparation composition for skin]
The present invention relates to a skin external preparation composition. Here, the "external preparation" means a drug that is directly applied to the body, excluding internal medicines and injections, and particularly means a drug that is applied to the skin (outer skin). Examples of external preparations include coating agents such as ointments, creams, gels, lotions, emulsions and hair tonics; and patches such as poultices, plasters, tapes and patches. The external preparation may be a drug, a quasi drug, or a cosmetic product. The skin external preparation composition means a composition used for the external preparation.
The amount of the external preparation for skin used in the present invention depends on the type of the external preparation, but may be the amount used in a normal external preparation. The amount of the external preparation composition for skin used is, for example, 0.01 to 10 g, preferably 0.05 to 5 g, and more preferably 0.1 to 1 g per 100 cm 2 of the skin surface of the body. Is.
[本発明の評価]
本発明の皮膚外用剤組成物は、有効成分であるバニリルアルキルエーテルの経時的な安定性(貯蔵安定性)を実現したものである。当該安定性は、バニリルアルキルエーテルの残存量を経時的に測定することによって評価することができる。当該安定性は薬物や化合物の貯蔵安定性の測定方法として周知な方法を使用して評価することが可能であるが、例えば、バニリルアルキルエーテルの濃度の経時的変化をHPLC等で測定することによって評価することができる。具体的には、調製した直後における外用剤中のバニリルアルキルエーテル濃度をHPLCにて測定する。その後、当該外用剤を50℃1ヶ月保存し、バニリルアルキルエーテル濃度を同様にして再測定し、以下の式からバニリルアルキルエーテルの残存率を求める。
バニリルアルキルエーテル残存率(質量%)
=(50℃1ヶ月保存後のバニリルアルキルエーテル濃度/
調製直後のバニリルアルキルエーテル濃度)×100
バニリルアルキルエーテルの残存率が高いほど、貯蔵安定性が高いと評価できる。バニリルアルキルエーテルの残存率は、例えば、50質量%以上であることが好ましく、より好ましくは55質量%以上であり、さらに好ましくは60質量%以上であり、特に好ましくは70質量%以上である。
[Evaluation of the present invention]
The external preparation composition for skin of the present invention realizes the stability of vanillyl alkyl ether, which is an active ingredient, over time (storage stability). The stability can be evaluated by measuring the residual amount of vanillyl alkyl ether over time. The stability can be evaluated by using a well-known method for measuring the storage stability of a drug or compound. For example, the change over time in the concentration of vanillyl alkyl ether can be measured by HPLC or the like. Can be evaluated by. Specifically, the vanillyl alkyl ether concentration in the external preparation immediately after preparation is measured by HPLC. Then, the external preparation is stored at 50 ° C. for 1 month, the vanillyl alkyl ether concentration is measured again in the same manner, and the residual ratio of vanillyl alkyl ether is determined from the following formula.
Vanillyl alkyl ether residual ratio (% by mass)
= (Vanillyl alkyl ether concentration after storage at 50 ° C for 1 month /
Vanillyl alkyl ether concentration immediately after preparation) x 100
It can be evaluated that the higher the residual ratio of vanillyl alkyl ether is, the higher the storage stability is. The residual ratio of the vanillyl alkyl ether is, for example, preferably 50% by mass or more, more preferably 55% by mass or more, further preferably 60% by mass or more, and particularly preferably 70% by mass or more. ..
一方、温感の評価は、本発明の皮膚外用剤組成物を身体に直接適用し、複数名のパネラーによって官能評価によって判断することが一般的である。例えば、複数名のパネラーに皮膚外用剤組成物を塗布し、例えば3〜10分、好ましくは5分程度放置した後に感じる温感を点数化して判断する。 On the other hand, the evaluation of warmth is generally judged by applying the external preparation composition for skin of the present invention directly to the body and performing a sensory evaluation by a plurality of panelists. For example, the skin external preparation composition is applied to a plurality of panelists, and the warmth felt after being left for 3 to 10 minutes, preferably about 5 minutes, is scored for judgment.
[外用剤]
本発明の皮膚外用剤組成物は、身体の凝りを低減するための外用剤を調製するために使用されてもよい。「身体の凝り」とは、首、肩、腰、腕、足等、体の各部分の筋肉疲労、血行不良、神経の圧迫等の状況を意味する。本発明の皮膚外用剤組成物は、(a)成分であるバニリルアルキルエーテルに基づく温感付与を、(b)成分である特定の界面活性剤によって良好に持続することにより、これらの症状を適切に低減又は消失することができる。
[External agent]
The external preparation for skin of the present invention may be used for preparing an external preparation for reducing stiffness of the body. "Body stiffness" means situations such as muscle fatigue, poor circulation, and nerve compression in various parts of the body such as the neck, shoulders, hips, arms, and legs. The external preparation composition for skin of the present invention causes these symptoms by satisfactorily sustaining the warming sensation based on the vanillyl alkyl ether which is the component (a) by the specific surfactant which is the component (b). It can be appropriately reduced or eliminated.
[皮膚外用剤組成物の調製]
本発明の皮膚外用剤組成物は、外用剤の製造方法として周知の方法を用いてもよいが、好ましくは、使用される成分の一部を溶剤に混合してゲルを調製し、さらに残りの成分を当該ゲルに加えて本発明の皮膚外用剤組成物を得ることが適当である。
具体的な調製方法としては、例えば次のようなものがある。まず、(h)増粘剤を(j)溶剤に分散し、20〜80℃、好ましくは30〜70℃、より好ましくは40〜60℃の温度で10〜120分、好ましくは20〜90分、さらに好ましくは30〜60分撹拌しながら加熱混合する。その後、20〜35℃、好ましくは25〜30℃まで冷却する。冷却した混合液に、(i)pH調整剤と任意の(j)溶剤とを加えた溶液を添加して当該混合液のpHを調節し(例えば、pH4.0〜9.0、好ましくはpH4.5〜8.5、より好ましくはpH5.0〜8.0)、目的のゲルを得ることができる。得られたゲルに本発明の必須成分である(a)バニリルアルキルエーテル、及び(b)ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤を加え、さらに上述したその他の成分を加えて本発明の皮膚外用剤組成物を得ることができる。なお、調製中の各成分の混合には、ホモミキサー、ディスパーミキサー、パドルミキサー等、周知のミキサーを使用することができる。
[Preparation of external preparation for skin composition]
The skin external preparation composition of the present invention may use a well-known method for producing an external preparation, but preferably, a part of the components used is mixed with a solvent to prepare a gel, and the rest thereof. It is appropriate to add the ingredients to the gel to obtain the external preparation composition for skin of the present invention.
Specific preparation methods include, for example, the following. First, (h) the thickener is dispersed in (j) a solvent, and the temperature is 20 to 80 ° C., preferably 30 to 70 ° C., more preferably 40 to 60 ° C. for 10 to 120 minutes, preferably 20 to 90 minutes. , More preferably, heat and mix with stirring for 30 to 60 minutes. Then, it is cooled to 20 to 35 ° C., preferably 25 to 30 ° C. The pH of the mixed solution is adjusted by adding a solution of (i) a pH adjuster and an arbitrary (j) solvent to the cooled mixed solution (for example, pH 4.0 to 9.0, preferably pH 4). The target gel can be obtained with a pH of .5-8.5, more preferably pH 5.0-8.0). One or more surfactants selected from (a) vanillyl alkyl ether and (b) polyoxyethylene polyoxypropylene alkyl ether and polyoxyethylene sorbitol fatty acid ester, which are essential components of the present invention, in the obtained gel. The above-mentioned other ingredients can be added to obtain the skin external preparation composition of the present invention. A well-known mixer such as a homo mixer, a dispenser mixer, or a paddle mixer can be used for mixing each component during preparation.
[皮膚外用剤組成物用容器]
本発明の皮膚外用剤組成物は、組成物の硬さに応じて、適した容器に充填することが出来る。例えば、液体から緩い粘度の皮膚外用剤組成物の場合、ボトル、缶及びプラスチックシートのパック等に充填できる。クリーム状や軟膏状の粘度の高い皮膚外用剤組成物の場合は、ボトル、缶及びチューブ等に充填することができる。
[Container for external preparation for skin]
The external preparation composition for skin of the present invention can be filled in a suitable container depending on the hardness of the composition. For example, in the case of a liquid to loosely viscous skin external preparation composition, it can be filled in bottles, cans, packs of plastic sheets and the like. In the case of a creamy or ointment-like highly viscous skin external preparation composition, it can be filled in bottles, cans, tubes and the like.
例えばボトルに充填された本皮膚外用剤組成物を皮膚に塗布する場合、ボトルから直接身体や掌に振り出して擦り込む方法や、霧状又は液体のまま吐出されるディスペンサーにて直接身体や掌に出して擦り込む方法、ドーム型の口元チューブの吐出部分を体に当てて直接身体へ出して、ドーム型口元にて擦り込む方法、ロールオンタイプの吐出部分を身体に当てて、吐出させた外用剤をロールを回転させて身体に擦り込む方法等がある。
容器の材質は、特に定めるものではないが、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート等のプラスチックや、アルミニウム等の金属、ガラス等がある。
[安定化剤]
本発明の一態様は、ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤を含有する、バニリルアルキルエーテルの安定化剤であり得る。当該バニリルアルキルエーテルは、上記(a)バニリルアルキルエーテルの項で記載したとおりであり、当該界面活性剤は、上記(b)界面活性剤の項で記載したとおりである。また、界面活性剤とバニリルアルキルエーテルの質量比は、上記(b)成分/(a)成分の質量比で示したとおりである。
ここで、「安定化」とは、有効成分であるバニリルアルキルエーテルの経時的な安定性(貯蔵安定性)を意味し、その安定性は、上記[本発明の評価]の項で説明したバニリルアルキルエーテル残存率で評価することが可能である。
本発明の安定化剤は、上記界面活性剤を有効成分とするが、さらに上述した他の成分(c)〜(w)を加えることができる。
以下、本発明を実施例及び比較例によって詳細に説明するが、本発明はこれらの記載に制限されるものではない。
For example, when applying the external preparation composition for skin filled in a bottle to the skin, it can be rubbed directly from the bottle onto the body or palm, or it can be directly applied to the body or palm with a dispenser that is discharged as a mist or liquid. A method of taking out and rubbing, a method of hitting the discharge part of the dome-shaped mouth tube against the body and directly putting it out to the body, and a method of rubbing with the dome-shaped mouth, a method of hitting the roll-on type discharge part against the body and discharging the external preparation There is a method of rotating the roll and rubbing it into the body.
The material of the container is not particularly specified, but includes plastics such as polyethylene, polypropylene and polyethylene terephthalate, metals such as aluminum, and glass.
[Stabilizer]
One aspect of the present invention may be a stabilizer for vanillyl alkyl ethers containing one or more surfactants selected from polyoxyethylene polyoxypropylene alkyl ethers and polyoxyethylene sorbitol fatty acid esters. The vanillyl alkyl ether is as described in the above section (a) Vanillyl alkyl ether, and the surfactant is as described in the above section (b) Surfactant. The mass ratio of the surfactant and the vanillyl alkyl ether is as shown by the mass ratio of the component (b) / component (a).
Here, "stabilization" means the stability of the active ingredient vanillyl alkyl ether over time (storage stability), and the stability has been described in the above section [Evaluation of the present invention]. It is possible to evaluate by the residual ratio of vanillyl alkyl ether.
The stabilizer of the present invention contains the above-mentioned surfactant as an active ingredient, but other components (c) to (w) described above can be further added.
Hereinafter, the present invention will be described in detail with reference to Examples and Comparative Examples, but the present invention is not limited to these descriptions.
<試料の調製>
以下の表1〜4に示す組成で各原料を混合し、実施例及び比較例の皮膚外用剤組成物を得た。実施例1を例に取ると、具体的には、以下のようにして皮膚外用剤組成物を製造した。なお、各成分の配合量は表1の通りである。
まず、(h)カルボマーを(j)水の一部(水全量に対して90質量%)に分散し、ホモミキサーを使用して60℃で30分間加熱撹拌した。その後、得られた混合液を30℃に冷却した。冷却した混合液に、(i)水酸化ナトリウムを(j)水の残部(水全量に対して10質量%)に加えた溶液を加えて、当該混合液のpHを6.5に調節し、目的のゲルを得た。(a)バニリルアルキルエーテル(温感付与成分・有効成分)、(b)ポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤、(c)冷涼感付与成分(任意)、、(d)ストレス軽減成分(任意)を加え、さらに残りの他の成分((e)1,3−ブチレングリコール、(e)グリセリン、(g)メチルパラベン)を加えてパドルミキサーを用いて撹拌し、本発明の実施例1の皮膚外用剤組成物を得た。
実施例2〜20及び比較例1〜9も、成分として表1〜4に記載の成分を使用した以外は実施例1と同様にして皮膚外用剤組成物を調製した。なお、使用した原料の詳細は、表5に示す。
<Sample preparation>
Each raw material was mixed with the compositions shown in Tables 1 to 4 below to obtain skin external preparation compositions of Examples and Comparative Examples. Taking Example 1 as an example, specifically, a skin external preparation composition was produced as follows. The blending amount of each component is as shown in Table 1.
First, (h) carbomer was dispersed in a part of (j) water (90% by mass based on the total amount of water), and the mixture was heated and stirred at 60 ° C. for 30 minutes using a homomixer. Then, the obtained mixed solution was cooled to 30 ° C. To the cooled mixture, a solution of (i) sodium hydroxide (j) added to the balance of water (10% by mass based on the total amount of water) was added to adjust the pH of the mixture to 6.5. The desired gel was obtained. (A) Vanillyl alkyl ether (warm-giving ingredient / active ingredient), (b) One or more surfactants selected from polyoxyethylene polyoxypropylene alkyl ether and polyoxyethylene sorbitol fatty acid ester, (c) A cooling sensation-imparting component (optional), (d) a stress-reducing component (optional) is added, and the remaining other components ((e) 1,3-butylene glycol, (e) glycerin, (g) methylparaben) are added. The mixture was stirred using a paddle mixer to obtain the skin external preparation composition of Example 1 of the present invention.
Also in Examples 2 to 20 and Comparative Examples 1 to 9, a skin external preparation composition was prepared in the same manner as in Example 1 except that the components shown in Tables 1 to 4 were used as the components. The details of the raw materials used are shown in Table 5.
<バニリルアルキルエーテル残存率>
上述の方法に従って調製した直後における各外用剤のバニリルアルキルエーテル濃度をHPLCにて測定した。その後、各剤を50℃1ヶ月保存した後におけるバニリルアルキルエーテル濃度を同様にして測定した。
バニリルアルキルエーテル残存率(質量%)
=(50℃1ヶ月保存後のバニリルアルキルエーテル濃度/
調製直後のバニリルアルキルエーテル濃度)×100
<Vanillyl alkyl ether residual rate>
The vanillyl alkyl ether concentration of each external preparation immediately after preparation according to the above method was measured by HPLC. Then, the vanillyl alkyl ether concentration after storing each agent at 50 ° C. for 1 month was measured in the same manner.
Vanillyl alkyl ether residual ratio (% by mass)
= (Vanillyl alkyl ether concentration after storage at 50 ° C for 1 month /
Vanillyl alkyl ether concentration immediately after preparation) x 100
<温感の評価>
各外用剤0.3gをパネラー10名の片側上腕部(約9cm2)に塗布し、塗布から5分経過後に感じた温感について、4段階(0点、1点、2点、3点)で回答してもらった。その結果を平均して下記評価基準(A〜D)により温感を評価した。
(評価項目)
3点:温感を強く感じた
2点:温感を感じた
1点:温感をわずかに感じた
0点:温感を感じなかった
(評価基準)
A:平均値が2.5以上
B:平均値が1.5以上2.5未満
C:平均値が0.5以上1.5未満
D:平均値が0.5未満
<Evaluation of warmth>
0.3 g of each external preparation was applied to one side upper arm (about 9 cm 2 ) of 10 panelists, and the feeling of warmth felt 5 minutes after application was 4 levels (0 points, 1 point, 2 points, 3 points). I got an answer in. The results were averaged and the warmth was evaluated according to the following evaluation criteria (A to D).
(Evaluation item)
3 points: I felt a strong feeling of warmth 2 points: I felt a feeling of warmth 1 point: I felt a feeling of warmth slightly 0 points: I did not feel a feeling of warmth (evaluation criteria)
A: Mean value is 2.5 or more B: Mean value is 1.5 or more and less than 2.5 C: Mean value is 0.5 or more and less than 1.5 D: Mean value is less than 0.5
<試験1>
試験1は、界面活性剤の種類の違いによる(a)成分のバニリルアルキルエーテルの残存率及び温感の評価結果を示す。各実施例及び比較例の成分の配合量は表1に示すとおりである。使用した界面活性剤およびそのHLBは表2(実施例)及び表3(比較例)に示されている。表2及び3から理解できるように、本発明の特定の界面活性剤を使用した場合、良好な(a)成分のバニリルアルキルエーテルの残存率及び高い温感評価が得られているが(表2)、本発明の特定の界面活性剤を使用しない表3では、良好な(a)成分のバニリルアルキルエーテルの残存率及び高い温感評価を得ることはできなかった。なお、実施例2、3、7、10、12〜17、及び20は、本発明の参考例である。
<Test 1>
Test 1 shows the evaluation results of the residual ratio and warmth of the vanillyl alkyl ether of the component (a) depending on the type of the surfactant. The blending amounts of the components of each Example and Comparative Example are as shown in Table 1. The surfactants used and their HLBs are shown in Table 2 (Examples) and Table 3 (Comparative Examples). As can be understood from Tables 2 and 3, when the specific surfactant of the present invention was used, a good residual ratio of vanillyl alkyl ether of the component (a) and a high warmth evaluation were obtained (Table). 2) In Table 3 in which the specific surfactant of the present invention was not used, it was not possible to obtain a good residual ratio of vanillyl alkyl ether of the component (a) and a high warmth evaluation. In addition, Examples 2, 3, 7, 10, 12 to 17, and 20 are reference examples of this invention.
表1
Table 1
表3
Table 3
<試験2>
上記試験1において最もバニリルアルキルエーテル残存率が良好であった実施例8のPOE(1)POP(4)セチルエーテルを(b)成分の界面活性剤として用い、当該界面活性剤の量を変更し、その他は表1の成分及び配合量と同様とし(水を除く)、皮膚外用剤組成物を調製して評価を行った。結果を以下の表4に示す。
表4
<Test 2>
The POE (1) POP (4) cetyl ether of Example 8 having the best residual ratio of vanillyl alkyl ether in Test 1 was used as the surfactant of the component (b), and the amount of the surfactant was changed. However, the other components and blending amounts in Table 1 were the same (excluding water), and a skin external preparation composition was prepared and evaluated. The results are shown in Table 4 below.
Table 4
上記表4の結果から、POE(1)POP(4)セチルエーテルの量が0.01〜10.0の場合に良好なバニリルアルキルエーテル残存率(質量%)と高い温感評価を得ることができることが分かった。一方、POE(1)POP(4)セチルエーテルの量がそれぞれ0.001質量%若しくは20.0質量%の場合、良好とは言えないが十分なバニリルアルキルエーテル残存率(質量%)と温感評価を得ることができた。 From the results in Table 4 above, a good vanillyl alkyl ether residual ratio (mass%) and a high warmth evaluation are obtained when the amount of POE (1) POP (4) cetyl ether is 0.01 to 10.0. I found that I could do it. On the other hand, when the amounts of POE (1) POP (4) cetyl ether are 0.001% by mass or 20.0% by mass, respectively, it is not good, but sufficient vanillyl alkyl ether residual ratio (mass%) and temperature. I was able to get a feeling evaluation.
表5
Table 5
Claims (9)
(b)HLBが10.5以下であるポリオキシエチレンポリオキシプロピレンアルキルエーテル及びポリオキシエチレンソルビット脂肪酸エステルから選択される1種以上の界面活性剤、
を含むことを特徴とする、皮膚外用剤組成物であって、前記皮膚外用剤組成物の質量に対して60質量%以上の水を更に含有する、皮膚外用剤組成物。 One or more surfactants selected from (a) vanillyl alkyl ethers and (b) polyoxyethylene polyoxypropylene alkyl ethers and polyoxyethylene sorbitol fatty acid esters having an HLB of 10.5 or less.
A skin external preparation composition comprising the above, further containing 60% by mass or more of water with respect to the mass of the skin external preparation composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016053087A JP6774767B2 (en) | 2016-03-16 | 2016-03-16 | Topical skin composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016053087A JP6774767B2 (en) | 2016-03-16 | 2016-03-16 | Topical skin composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017165687A JP2017165687A (en) | 2017-09-21 |
JP6774767B2 true JP6774767B2 (en) | 2020-10-28 |
Family
ID=59909687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016053087A Active JP6774767B2 (en) | 2016-03-16 | 2016-03-16 | Topical skin composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6774767B2 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4051111B2 (en) * | 1997-10-13 | 2008-02-20 | 花王株式会社 | Bath agent composition |
JP4017758B2 (en) * | 1998-08-04 | 2007-12-05 | 高砂香料工業株式会社 | Cooling agent composition |
JP2003095843A (en) * | 2001-09-21 | 2003-04-03 | Sunstar Inc | Nonaqueous cosmetic |
JP2003095842A (en) * | 2001-09-21 | 2003-04-03 | Sunstar Inc | Cosmetic |
JP2003095841A (en) * | 2001-09-21 | 2003-04-03 | Sunstar Inc | Cosmetic |
JP2004161708A (en) * | 2002-11-15 | 2004-06-10 | Pola Chem Ind Inc | Cosmetic for ameliorating edema |
JP2006063168A (en) * | 2004-08-26 | 2006-03-09 | Daishoo:Kk | Microcapsule formulation containing fragrance ingredient imparting sedative effect |
-
2016
- 2016-03-16 JP JP2016053087A patent/JP6774767B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017165687A (en) | 2017-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1689494B1 (en) | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use | |
TWI417112B (en) | Emulsified composition | |
KR20060130215A (en) | Oil-in-water emulsified composition, and external preparation for skin and cosmetics using the composition | |
JP7450324B2 (en) | Composition containing D-chiro-inositol | |
JP7063265B2 (en) | Creamy composition | |
JP6367003B2 (en) | Oil-in-water emulsified cosmetic | |
JP2011213676A (en) | O/w-type emulsion composition | |
JP6376835B2 (en) | Topical skin preparation | |
JP2003300856A (en) | Cosmetic composition | |
JP2023133519A (en) | Topical composition | |
JP6483489B2 (en) | Cosmetics | |
JP2016003208A (en) | External composition | |
JP6954895B2 (en) | Hyperfat and personal care compositions | |
JP6774767B2 (en) | Topical skin composition | |
JP4672328B2 (en) | Skin external preparation containing ascorbic acid derivative salt, method for stabilizing skin external preparation, and stabilizer | |
EP3533437A1 (en) | Composition containing linoleic acid | |
WO2022224380A1 (en) | Cosmetic | |
KR101490833B1 (en) | Cleanser cosmetic composition containing polymer matrix including carbonated water | |
JP5632134B2 (en) | Cosmetics | |
JP7092494B2 (en) | Water-in-oil emulsification composition | |
JP5829578B2 (en) | Thickening composition containing acylated amino acids | |
JP2003238381A (en) | Cosmetic composition | |
JPH08268866A (en) | Dermal preparation for external use | |
TWI849213B (en) | Additive composition for preventing precipitation of vitamin c | |
JP7546113B1 (en) | Oil-in-water emulsion cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181219 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190917 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190926 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191101 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200123 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200603 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200803 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200903 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201005 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6774767 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |